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• Although asbestos is no longer used in many products, it will 
remain a public health concern well into the 21st century. 
Key Concepts 
• Intact asbestos sources in the home release few fibers and 
should be left undisturbed. Damaged or crumbling materials 
should be repaired or removed only by certified asbestos-
removal professionals. 
• Asbestos exposure is associated with parenchymal 
asbestosis, asbestos-related pleural abnormalities, 
mesothelioma, and lung cancer, and it may be associated 
with cancer at some extra thoracic sites. 





This educational case study document is one in a series of self-
instructional publications designed to increase the primary care 
provider’s knowledge of hazardous substances in the 
environment and to promote the adoption of medical practices 
that aid in the evaluation and care of potentially exposed 
patients. The complete series of Case Studies in Environmental 
Medicine is located on the ATSDR Web site at URL: 
www.atsdr.cdc.gov/csem/. In addition, the downloadable PDF 
version of this educational series and other environmental 
medicine materials provides content in an electronic, printable 
format, especially for those who may lack adequate Internet 
service. 
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See Internet address www2.cdc.gov/atsdrce/ for more 
information about continuing medical education credits, 
continuing nursing education credits, and other continuing 
education units. 
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How to Use This Course 
Introduction The goal of Case Studies in Environmental Medicine (CSEM) is 
to increase the primary care provider’s knowledge of hazardous 
substances in the environment and to help in evaluating and 
treating potentially exposed patients. This CSEM focuses on 
asbestos toxicity. 
Available Versions Two versions of the Asbestos Toxicity CSEM are available: 
• the HTML version 
http://www.atsdr.cdc.gov/csem/asbestos/cover2.html 
provides content through the Internet; 
• the downloadable PDF version provides content in an 
electronic, printable format, especially for those who may 
lack adequate Internet service. 
The HTML version offers interactive exercises and prescriptive 
feedback to the user. 
Instructions To make the most effective use of this course, we recommend 
that you 
• take the initial check to assess your current knowledge 
about asbestos toxicity  
• read the title, learning objectives, text, and key points in 
each section 
• complete the progress check exercises at the end of each 
section and check your answers 
• complete and submit your Assessment and Posttest 
responses online if you wish to obtain continuing education 
credit. Continuing education certificates can be printed 
immediately upon completion 
Instructional 
Format 
This course is designed to help you learn efficiently. Topics are 
clearly labeled so that you can skip sections or quickly scan 
sections you are already familiar with. This labeling will also 
allow you to use this training material as a handy reference. To 
help you identify and absorb important content quickly, each 
section is structured as follows: 
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Section Element Purpose 
Title Serves as a “focus question” that you should be able to answer 
after completing the section 
Learning Objectives Describes specific content addressed in each section and 
focuses your attention on important points 
Text Provides the information you need to answer the focus 
question(s) and achieve the learning objectives 
Key Points Highlights important issues and helps you review 
Progress Check 
exercises 
Enables you to test yourself to determine whether you have 
mastered the learning objectives 
Progress Check 
answers 
Provides feedback to ensure you understand the content and 
can locate information in the text 
Learning Objectives 
Upon completion of the Asbestos Toxicity CSEM, you should 
be able to 
Topic Objectives 
What Is Asbestos? • Explain what asbestos is. 
Where Is Asbestos Found? • Identify where asbestos exists in the United 
States. 
• Describe how asbestos is released into the air. 
How Are People Exposed to 
Asbestos? 
• Identify the most important route of exposure 
to asbestos. 
Who Is At Risk of exposure to 
Asbestos? 
• Name the populations most heavily exposed 
to asbestos. 
• Describe Who Is At Risk of domestic exposure 
to asbestos. 
What Are the U.S. Standards 
for Asbestos Levels? 
• Explain the Occupational Safety and Health 
Administration (OSHA) permissible exposure 
level (PEL) for asbestos. 
• Explain the Environmental Protection Agency’s 
(EPA) maximum contaminant level (MCL) for 
asbestos in drinking water. 
What Is the Biologic Fate of 
Asbestos? 
• Identify where asbestos fibers are most likely 
to be retained in the body. 
How Does Asbestos Induce 
Pathogenic Changes? 
• Describe the three mechanisms by which 
scientists hypothesize asbestos induces 
pathogenic changes in the lungs. 
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What Respiratory Conditions 
Are Associated with Asbestos? 
• Describe the four respiratory diseases 
associated with asbestos. 
What other health conditions 
can be associated with 
Asbestos? 
• Identify nonrespiratory conditions that might 
be associated with exposure to asbestos. 
How Should Patients Exposed 
to Asbestos Be Evaluated? 
• Identify the primary focuses of the exposure 
history and medical history. 
• Describe the most typical findings on patient 
examination. 
What tests can assist with 
diagnosis of asbestos-related 
diseases? 
• Describe pulmonary function test findings 
associated with parenchymal asbestosis. 
• Describe chest radiograph findings associated 
with other asbestos associated diseases. 
How Should Patients Exposed 
to Asbestos Be Managed and 
Treated? 
• Identify two primary strategies for managing 
asbestos-associated diseases. 
• Describe specific strategies for managing 
parenchymal asbestosis. 
What Instructions Should Be 
Given to Patients? 
• List four instructions for patient self care and 
two instructions for clinical follow up. 
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Initial Check 
Instructions This Initial Check will help you assess your current knowledge 
and skill level about asbestos toxicity. To take the Initial Check, 
read the case below, answer the questions that follow, and then 
compare your answers with the answers provided. 
Case A 66-year-old retired male presents with dyspnea on exertion. 
He first noticed the shortness of breath several months ago but 
was not concerned because it seemed so minor; he attributed it 
to aging. During the past few months, however, the dyspnea on 
exertion has gradually worsened. 
The patient has no other symptoms of respiratory or cardiac 
disease. His medical history is unremarkable except for 
• an old back injury (compression fracture of L4) sustained 
while working as an electrician at a local shipbuilding facility 
and 
• a 25 pack-year history of smoking, though the patient quit 
smoking 5 years ago. 
On physical examination, the patient is in no apparent distress. 
Auscultation reveals bibasilar end inspiratory rales. There are 
no signs of cyanosis, no clubbing of the fingers, and no 
peripheral edema. Heart sounds are normal, as are the results 
of the rest of the physical examination. 
Initial Check 
Questions 
1. What further workup is required for this patient? 
2. The exposure history indicates a 15-year history of 
exposure to asbestos at the shipyard, beginning 35 years 
ago and ending 20 years ago. The patient does not know 
the exposure levels but notes that he used a respirator 
during the last 5 years at the shipyard. In addition, when he 
was 21 years old, he swept floors at a vermiculite handling 
facility for a summer. He notes that the vermiculite plant 
was extremely dusty, but he was told it was just “nuisance 
dust.”  
Are the patient’s symptoms likely to be related to asbestos 
exposure? Why or why not? 
3. The radiologist (a certified “B reader”) finds small, irregular 
opacities in both lung bases consistent with early-stage 
parenchymal asbestosis. The pulmonary function tests 
reveal a mostly restrictive pattern of deficits, with 
decreased carbon monoxide diffusing capacity (DLco). You 
refer the patient to a pulmonologist. The pulmonologist 
diagnoses parenchymal asbestosis on the basis of the 
patient’s exposure history, latency of symptoms (occurring 
45 years after first exposure), chest x-ray findings, and 
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spirometry results. How will you manage the patient’s 
condition? 
4. Is the patient at risk for other asbestos-associated 
diseases? Why or why not? 
5. Are the patient’s family members at risk for asbestos-
associated disease? 
6. The patient has been married for 46 years and has four 
children. He notes that his wife laundered all his clothes 
from work, including his clothes from the summer job at the 
vermiculite plant and those from his job at the shipbuilding 
facility. His children had only incidental exposure from 
hugging him after work. The patient’s wife, a two-pack-a-
day smoker, has recently lost weight and developed sharp 
pains in her lower chest.  
Could the wife’s recent weight loss and chest pain be 
related to her husband’s occupational exposure to 
Asbestos? What work-up do you suggest for the patient’s 
wife? 
7. The patient asks if his children are at risk of asbestos-
associated disease. How do you answer? 
1. The exertional dyspnea and bibasilar end inspiratory rales 
are suggestive of some type of interstitial pneumonitis. 
Because of the patient’s history of work at a shipbuilding 
facility, a detailed exposure history is warranted. You should 
ask the patient about 
Initial Check 
Answers 
• possible exposures (especially to asbestos) at the 
shipbuilding facility 
• other jobs at which the patient may have been exposed 
directly or indirectly to asbestos 
• the source, intensity, frequency, and duration of any 
exposure 
• the time elapsed since first exposure 
• workplace dust measurements or cumulative fiber dose, 
if extant 
• use of personal protective equipment 
• other sources of exposure, including paraoccupational 
exposures to or from family members and other 
household contacts 
• sources of environmental exposure, such as a residence 
near a source of naturally occurring asbestos or hobbies 
or recreational activities that involve materials 
contaminated with asbestos (e.g., home repairs or auto 
maintenance). 
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In addition to taking a detailed exposure history, it is 
prudent to order chest X-ray and pulmonary function tests. 
The information for this answer comes from section How 
should patients exposed to asbestos be evaluated?
2. Yes, the patient’s condition is likely to be related to 
asbestos exposure. Diagnoses to consider include  
• parenchymal asbestosis 
• idiopathic pulmonary fibrosis 
• other pneumoconiosis 
• hypersensitivity pneumonitis 
• sarcoidosis and other interstitial pulmonary diseases 
Several aspects of the patient’s case point to parenchymal 
asbestosis as a likely diagnosis: 
• history of exposure to asbestos in the shipbuilding 
facility and vermiculite handling plant 
• onset of symptoms many years after the exposures 
(consistent with a long latency period) 
• insidious onset of dyspnea on exertion, and 
• bibasilar end inspiratory rales on auscultation. 
The results of the chest X-ray (which should be read by a 
certified “B reader”) and pulmonary function tests will help 
with the differential diagnosis. 
The information for this answer comes from section How 
Should Patients Exposed to Asbestos Be Evaluated?
3. To manage this patient’s condition, you will  
• advise the patient to avoid any further exposure to 
asbestos, smoke, and other respiratory irritants as 
practical 
• provide regular pneumococcal and annual influenza 
vaccines 
• advise the patient to contact you at any sign of 
respiratory infection 
• aggressively treat any respiratory infections that 
develop in the patient 
• advise the patient to contact you at any sign of other 
health changes, particularly changes that might be early 
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signs of neoplasia (e.g., hoarseness, sores in the mouth, 
blood in urine or stool) 
• perform colon cancer screening in accordance with 
American Cancer Society guidelines 
• schedule regular follow-up visits to monitor progression 
of the parenchymal asbestosis and possible development 
of other asbestos-associated diseases. 
• document any impairments related to work-related 
asbestos exposure 
• notify the patient that he has an occupational disease. 
In states where occupational lung diseases are 
reportable conditions, report this case of asbestosis to 
the health department 
The information for this answer comes from section How 
Should Patients Exposed to Asbestos Be Managed and 
Treated?
4. Yes, the patient is at risk of other asbestos-associated 
diseases. The patient’s past exposures to asbestos were 
significant enough to have led to the development of 
parenchymal asbestosis. These exposures can also lead to 
the development of other asbestos-associated diseases such 
as asbestos-related pleural abnormalities, lung carcinoma, 
and pleural or peritoneal mesothelioma.  
The information for this answer comes from section What 
Other Health Conditions Are Associated with Asbestos?
5. Possibly. While taking the exposure history, it is important 
to ask about possible paraoccupational exposures to family 
members and other household contacts. These can include 
inhalation of asbestos fibers from  
• the worker’s skin, hair, and clothing (if PPE was not 
used) 
• air and dust from local vermiculite- or asbestos-handling 
facilities. 
• air and dust from local mining operations or other 
blasting/disruption of asbestos-bearing rock. 
You should also ask about other possible exposure sources such 
as 
• materials used for hobbies and recreation 
• outdoor activities that could involve exposure to 
naturally occurring asbestos particularly if the patient 
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lives near a geologic source 
• vermiculite attic insulation contaminated with asbestos. 
These types of exposures could place family members and 
other household contacts at risk of asbestos-associated 
disease. 
The information for this answer comes from section Who Is 
At Risk of Exposure to Asbestos?
6. Yes, the wife’s symptoms could be related to her husband’s 
occupational exposures to asbestos. Given that she 
laundered her husband’s work clothes when he had two jobs 
involving asbestos, she could have received significant 
paraoccupational exposures to asbestos. To determine 
whether these exposures led to an asbestos-associated 
disease, you recommend that the patient’s wife:  
• come in for an office visit 
• receive chest X-rays 
• undergo pulmonary function tests 
The wife’s chest X-rays show a pleural thickening associated 
with a slight pleural effusion on the lower right lung field. 
You refer the wife to a pulmonologist, who performs a 
computed tomography (CT) scan and a biopsy of the pleural 
mass. The pulmonologist diagnoses pleural mesothelioma, 
refers her to a cancer center, and provides the family with a 
referral for psychosocial support. 
The information for this answer comes from section How 
Should Patients Exposed to Asbestos Be Evaluated?
7. You explain that the risk of asbestos-associated diseases, 
especially parenchymal asbestosis, is generally dose-related 
and that asbestosis develops in approximately 50% of 
adults with heavy industrial exposures. The children 
received paraoccupational exposure to asbestos from dust 
and residue carried home on their father’s skin and clothing, 
so their risk of asbestos-associated disease is less than the 
occupational risk. You note that asbestos-associated 
disease, particularly mesothelioma, can occur with 
paraoccupational and even background exposures to 
asbestos but at background levels, the risk is low.  
The information for this answer comes from section What 
Respiratory Conditions Are Associated with Asbestos?
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What Is Asbestos? 
Learning 
Objective 
Upon completion of this section, you should be able to 
• explain what asbestos is. 
Definition Asbestos is the name given to a group of six naturally occurring 
fibrous silicate minerals that have been widely used in 
commercial products. Asbestos is composed of silicate chains 
bonded with magnesium, iron, calcium, aluminum, and sodium 
or trace elements to form long, thin, separable fibers. These 
fibers are often arranged in parallel or matted masses. 
Asbestos occurs naturally, but much of its presence in the 
environment stems from mining and commercial uses. 





Long, flexible fibers Brittle with a rod or needle shape  
Member: chrysotile Members: crocidolite, amosite, 
anthophyllite, tremolite, actinolite, 
winchite, richterite  
Accounts for 93% of world’s commercial, 
purposeful use of asbestos 
Accounts for 7% of commercial, purposeful 
use of asbestos  
Properties Asbestos was widely used commercially because of its 
• high tensile strength 
• resistance to acids and alkalis 
• resistance to heat and flame 
• flexibility 
These properties make asbestos commercially useful but also 
stable in the environment. Asbestos is nonbiodegradable. Once 
released to the environment, asbestos tends to persist. 
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Key Points • Asbestos is a group of fibrous silicate minerals. 
• There are two classes of asbestos: serpentine and 
amphibole. 
• Asbestos was once used more widely for commercial 
purposes. 
• Asbestos is stable and persists in the environment. 
Progress Check 
1. Asbestos is a 
A. group of fibrous mineral silicates 
B. naturally occurring substance 
C. commercially used substance 
D. all of the above 
To review relevant content, see Definition in this section.
2. Asbestos is useful commercially, but also persists in the environment, because it 
is 
A. reactive with water, acids, alkalis, and other chemicals 
B. strong and stable 
C. rigid and inflexible 
D. all of the above 
To review relevant content, see Properties in this section.
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Where Is Asbestos Found? 
Learning Objective Upon completion of this section, you should be able to 
• identify where asbestos still exists in the United 
States. 
• describe how asbestos is released into the air. 
Introduction Asbestos was widely used commercially until the 1970s, 
when health concerns led to some uses being banned 
and some voluntary phase outs (Seidman and Selikoff, 
1990). Mining and milling of the raw material and 
production of asbestos has declined since the early 
1970s, but asbestos is still used in some construction 
materials. Some asbestos-containing products, such as 
amphibole-contaminated vermiculite insulation, remain 
in many homes in the United States. Asbestos fibers 
are released into the air and dust when asbestos-
containing materials are loose, crumbling, or disturbed. 
In addition to being at risk for exposure from the 
commercial uses of asbestos, people in some areas of 
the world are at risk because of geological deposits of 
asbestos near the surface which release asbestos if 
disturbed. 




Today, most asbestos used in the United States is 
imported. Asbestos is still used in 
• brake pads 
• automobile clutches 
• roofing materials 
• vinyl tile 
• and, imported cement pipe and corrugated sheeting 
(American Thoracic Society 2004). 
Former Commercial Uses Until the 1970s, asbestos was widely used in the 
construction, shipbuilding, and automotive industries, 
among others. For example, asbestos was formerly 
used in the following items 
• boilers and heating vessels 
• cement pipe 
• clutch, brake, and transmission components 
• conduits for electrical wire 
• corrosive chemical containers 
• electric motor components 
• heat-protective pads 
• laboratory furniture 
• paper products 
• pipe covering 
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• roofing products 
• sealants and coatings 
• insulation products, 
• textiles (including curtains) 
These materials remain in many buildings, ships, and 




Asbestos has been a contaminant in other products 
such as 
• vermiculite in potting soil 
• vermiculite home insulation 
Vermiculite contaminated with amphibole asbestos was 
produced as late as 1990 from a mine near Libby, 
Montana. The mined ore was processed at more than 
200 sites around the country, and contaminated 
vermiculite products were distributed nationally (ATSDR 
2001a). Although all the new vermiculite in potting soil 
is amphibole free, pre-1990 products from that source 
may contain amphiboles, and many homes may still 
have vermiculite insulation in their attics. 
For more information on amphibole asbestos and 
vermiculite insulation, please refer to the ATSDR 
website on asbestos. 
Homes and Buildings Some home-attic insulating materials produced before 
1975 contained asbestos. Of particular concern is 
vermiculite insulation contaminated with amphibole 
asbestos, because this is a loose material that can 
easily be disturbed, causing asbestos fibers to be 
released into the air. Asbestos in friable (easily 
pulverized or crumbled) material is also a concern. 
Asbestos embedded in solid materials (such as 
wallboards) is less easily disturbed and therefore less 
likely to be released into the air unless it is cut, drilled, 
or sanded. 
Many other home and building materials produced 
before 1975 contained asbestos including the following 
• duct and home insulation 
• fire protection panels 
• fireplace artificial logs or ashes 
• fuse box liners 
• gypsum wallboard 
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• hair dryers 
• toasters 
• heater register tape and insulation 
• joint compounds 
• patching and spackling compounds 
• pipe or boiler insulation 
• pot holders and ironing board pads 
• sheet vinyl or floor tiles 
• shingles 
• textured acoustical ceiling 
• textured paints 
• underlayment for flooring and carpets 
The Natural Environment Because of widespread human use of asbestos, its 
fibers are found in many or most parts of the 
environment. These background levels are extremely 
low, about 0.0001 fibers/cc of air (Holland and Smith 
2003). 
Asbestos is also present in the environment naturally, 
primarily in underground rock. In most areas, the rock 
is too deep to be disturbed easily, so asbestos fibers 
are not released into the air. In some areas, such as 
parts of California, Virginia and New Jersey (and across 
the globe in Turkey and Corsica), asbestos-bearing rock 
is close enough to the surface that construction and 
other human activities can disturb it, leading to release 
of high concentrations of asbestos fibers into the air 
and dust (ATSDR 2001a; Hasanoglu et al. 2003; Luo et 
al. 2003). For a map of sites in the United States where 
naturally occurring asbestos outcroppings, please see: 
http://www.atsdr.cdc.gov/asbestos/sites/national_map/
The table below shows examples of sources of asbestos 
in the environment. 
Asbestos Source Environmental Contamination 
Mining, milling, and weathering of 
asbestos-bearing rock 
Outdoor air and dust 
Release of fibers from disturbed building 
materials (e.g., vermiculite insulation) 
Indoor air 
Manufacture, wear, and disposal of 
asbestos-containing products 
Outdoor and indoor air and dust 
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Release of fibers from brake linings or 
crushed asbestos-containing rock used in 
road construction 
Street dust 
Erosion of natural land sources, discarded 
mine and mill tailings, asbestos cement 
pipe, disintegration of other asbestos-
containing materials transported by rain 
Drinking water 
Key Points • Until the 1970s, asbestos was widely used in the 
construction, shipbuilding, and automotive industries. 
• Asbestos-contaminated vermiculite materials were produced 
until 1990. 
• Some home insulation and other building materials 
produced before 1975 contain asbestos. 
• Asbestos fibers are mainly released into the air and dust 
when asbestos-containing materials are loose, crumbling, or 
disturbed. 
• In a few areas, asbestos-bearing rock close to the earth’s 
surface can be disturbed and release high concentrations of 
asbestos fibers into the air and dust. 
Progress Check 
3. Asbestos currently in the environment comes from 
A. current production of commercial products and building mater 
B. past production of commercial products and building materials 
C. natural release of asbestos fibers from weathered rock 
D. all of the above 
To review relevant content, see Natural Environment in this section.
4. Asbestos fibers are released into the air mainly when 
1. asbestos-containing materials are loose, crumbling, or disturbed 
2. asbestos is fixed in solid materials such as wallboard 
3. asbestos-bearing rock lays unexposed deep underground 
4. all of the above 
To review relevant content, see Introduction in this section. 
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How Are People Exposed to Asbestos? 
Learning 
Objectives 
Upon completion of this section, you should be able to 
• identify the most important route of exposure to asbestos 
Introduction Exposure to asbestos can occur when asbestos-containing 
material (manmade or natural) is loose, crumbling, or 
disturbed, releasing asbestos fibers into the air and dust. 
Asbestos that is embedded or contained in undisturbed solid 
materials presents a negligible risk of exposure. 
The primary route of asbestos entry into the body is inhalation 
of air or dust that contains asbestos fibers. Asbestos can also 
enter the body via ingestion. With dermal exposure, asbestos 
fibers may lodge in the skin.  
Inhalation The air pathway is the most important route of exposure to 
asbestos, and the route that most commonly leads to illness. 
Exposure scenarios include inhalation of contaminated air and 
dust 
• during work with asbestos 
• during work in the same space as others working with 
asbestos 
• on worker’s skin, hair, and clothing 
• in areas surrounding a mining operation 
• in areas of the world where construction or other human 
activity (such as gardening) results in disturbance of 
natural outcrops of asbestos-bearing rock 
• in homes and buildings where renovations or demolitions 
disturb asbestos-containing building materials 
The first four scenarios were common until the 1970s, when 
the Environmental Protection Agency (EPA) began to regulate 
the industrial uses of asbestos and the Occupational Safety 
Health Administration (OSHA) developed workplace exposure 
standards (Seidman and Selikoff, 1990). Today, the last two 
scenarios are the more common because of declining use of 
asbestos in developed countries (British Thoracic Society 
2001). 
Ingestion Ingestion—a minor pathway of exposure—occurs through 
• swallowing material removed from the lungs via 
tracheociliary clearance by a person who has inhaled 
asbestos fibers into the lungs 
• drinking water contaminated with asbestos for example, 
from erosion of natural land sources, discarded mine and 
mill tailings, asbestos cement pipe, or disintegration of 
other asbestos-containing materials transported by rain 
Asbestos levels in most water supplies are well below the EPA 
maximum contaminant level (MCL), so significant exposure by 
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drinking water is uncommon. 
Skin Today, with the advent of personal protective equipment, 
dermal contact is rarely a significant exposure pathway. In the 
past, handling asbestos could result in heavy dermal contact 
and exposure. Asbestos fibers could become lodged in the skin, 
producing a callus or corn, but not more serious health effects. 
Key Points • The air pathway (inhalation of contaminated air or dust) is 
the most important route of exposure to asbestos, the route 
that most commonly leads to illness. 
• Ingestion is a minor exposure pathway, but exposure can 
occur after swallowing of material cleared from the lungs. 








C. dermal contact 
D. all are equally important 
To review relevant content, see Inhalation in this section. 
Page 19 of 73 
 
Agency for Toxic Substances and Disease Registry Asbestos Toxicity 
Case Studies in Environmental Medicine (CSEM) 
  
Page 20 of 73 
 
Who Is at Risk of Exposure to Asbestos? 
Learning 
Objectives 
Upon completion of this section, you should be able to 
• Name the populations most heavily exposed to asbestos. 
• Describe who is at risk of domestic exposure to asbestos. 
Introduction In the past, asbestos exposure was associated mainly with mining 
and milling of the raw material and with workers engaged in 
construction and product manufacture or use of end products. In 
the industrialized west, these heavy asbestos exposures peaked 
during the 1960s and 1970s and then it declined as worker 
protection regulations were put in place and later as industrial use 
of asbestos decreased. Because of long latency periods (10–40 
years), workers exposed to asbestos in the 1960s and 1970s are 
now manifesting asbestos-associated diseases. Indeed, the 
incidence of asbestos-associated diseases among people 
occupationally exposed is beginning to peak and will likely begin to 
decline some time in the next 2 decades. National statistics that 
illustrate this trend are available at 
www.cdc.gov/niosh/topics/surveillance/ords/NationalStatistics.html. 
Today in the United States, most occupational exposures occur 
during repair, renovation, removal, or maintenance of asbestos that 
was installed years ago. People can also be exposed at home, both 
to old sources of asbestos as a result of activities such as home 
renovation or to new sources of asbestos as a result of certain 
types of recreational activities and hobbies such as auto repairs or 





In the past, many occupations entailed exposures to asbestos (see 
table below). Studies have documented the scale of the problem. 
• In the United States, an estimated 27 million workers were 
exposed to aerosolized asbestos fibers between 1940 and 1979 
(Nicholson et al. 1982). 
Occupations Businesses where workers may be exposed to asbestos 
• Auto 
mechanics 









• Asbestos product manufacturing (insulation, roofing, 
building materials) 
• Automotive repair shops ( especially those that involve 
repair of brakes, clutches) 
• Construction companies 
• Maritime companies 
• Mining companies 
• Offshore rust removal businesses 
• Oil refineries 
• Power plants 
• Railroads 
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• Floor covering 
workers 
• Manufacturers of sand or abrasives 
• Shipbuilders, ship lines, and ship yards 
• Furnace 
workers 
• Steel manufacturers 
• Tile cutters 
• Glazers 
• Grinders 
• Hod carriers 
• Insulators 

























• Steam fitters 
• Tile setters 
• U.S. Navy 
personnel 
• Welders 




Secondary exposure occurred when people who did not work 
directly with asbestos were nevertheless exposed to fibers as a 
result of sharing workspace where others handled asbestos. 
For example, electricians who worked in shipyards were 
exposed because asbestos was being used to coat the ships’ 




In the past, because of a lack of proper industrial hygiene, 
asbestos workers went home covered in asbestos dust. The 
workers’ families and other household contacts were then 
exposed via inhalation of asbestos dust 
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• from workers’ skin, hair, and clothing, and 
• during laundering of contaminated work clothes. 
A mortality study of 878 household contacts of asbestos 
workers revealed that 4 out of 115 total deaths were from 
pleural mesothelioma and that the rate of deaths from all 
types of cancer was doubled (Joubert et al. 1991)  
In addition, asbestos was released into the air and soil around 
facilities such as refineries, power plants, factories handling 
asbestos, shipyards, steel mills, vermiculite mines, and 
building demolitions. People living around these facilities were 




Currently, the people most heavily exposed to asbestos in the 
United States are those in construction trades. This population 
includes an estimated 1.3 million construction workers as well 
as workers in building and equipment maintenance (American 
Thoracic Society 2004). Because most asbestos was used in 
construction, and two-thirds of asbestos produced is still used 
in this trade, risk to these workers can be considerable if the 




As noted previously, some home attic insulation and many 
other home and building materials produced before 1975 
contain asbestos. People who live in homes with these 
materials are at risk of exposure if the materials are loose, 
crumbling, or disturbed by household activities or renovations. 
In such cases, the asbestos materials should be removed or 
encapsulated by a trained and certified asbestos contractor. 
For information on where to find certified asbestos contractors 
in your state, contact your local health department. 
On the other hand, asbestos contained in intact solid material 
poses a negligible risk of exposure. A 1992 study of indoor air 
in homes and schools with asbestos-containing materials 
found an average concentration of 0.0001 fibers/cc (Lee et al. 
1992). 
There are many ways that people can also be exposed to 
asbestos through hobbies and recreational activities that entail 
contact with materials containing asbestos; some examples 
are such activities as home renovation, auto repair, and urban 
spelunking. In places where naturally occurring asbestos is 
close to the earth’s surface, activities such as gardening and 
dirt biking can cause exposures if asbestos-bearing rock is 
disturbed. 
 
Exposure at School Measurable asbestos levels in schools are usually 100 to 1,000 
times below OSHA’s permissible exposure limit of 0.1 fibers/cc 
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of air for asbestos (Holland and Smith 2003). However, ATSDR 
does not use occupational standards when considering the 
risks to health of the general population from asbestos in the 
general environment. A specific environmental health risk 
assessment process is used. 
Over time, public concern led to widespread removal and 
abatement programs. Some facilities have higher levels of 
airborne asbestos after removal than before, highlighting the 




No known truly unexposed group exists in the world. The 
cumulative risk of background exposures is probably minor, 
however, and these concentrations cannot be reduced 
(Hillerdahl 1999). Any source of pollution that releases 
significant amounts of asbestos fibers should be eliminated, 





Most vermiculite used today contains low or non-detectable 
levels of asbestos. However, the vermiculite mined in Libby, 
Montana, from the turn of the 20th century to 1990 was 
contaminated with various fibrous amphiboles, including 
tremolite asbestos, and constituted 95% of the vermiculite 
used in the United States during that time. The vermiculite 
operations in Libby, Montana, are a good example of the many 
ways people can be at risk of asbestos exposure. In this 
example, mining of the asbestos- contaminated vermiculite 
ore in Libby resulted in asbestos exposures to 
• miners 
• household contacts of miners and other Libby asbestos 
workers 
• children playing in piles of vermiculite in the area 
• residents of nearby towns (where the air was contaminated 
by industrial activities involving asbestos) 
• workers who handled the vermiculite in vermiculite 
exfoliation and handling sites throughout the United States 
after it was shipped there from Libby 
• people who live in homes with vermiculite home insulation 
This vermiculite was also used in potting soil, but EPA 
concluded that consumers “face only a minimal health risk 
from occasionally using vermiculite products at home or in 
their gardens” (EPA 2000). 
For more information about amphibole-contaminated 
vermiculite, see 
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• an ATSDR map of 28 priority vermiculite exfoliating sites at 
http://www.atsdr.cdc.gov/asbestos/sites/national_map/ 
• an EPA fact sheet about how to recognize and avoid 
exposure to vermiculite insulation in homes at 
http://www.epa.gov/asbestos/pubs/insulation.html 
• an EPA fact sheet about how to avoid asbestos exposures 
while using potting soils at 
http://www.epa.gov/asbestos/pubs/vermfacts.pdf 
• Today, the populations most heavily exposed to asbestos 
are those in construction trades. 
Key Points 
• In the past, pipe fitters, shipyard workers, military 
workers, automobile mechanics, and people in many other 
occupations were also exposed. 
• In the past, household contacts of asbestos workers were 
exposed to asbestos dust on workers’ skin and clothing. 
• People in homes and buildings with loose, crumbling, or 
disturbed asbestos materials can be exposed to asbestos. 
• During renovations or abatement, asbestos materials 
should be encapsulated or removed by trained and certified 
asbestos contractors. 
• Asbestos embedded in intact solid materials poses little 
risk of exposure as long as it remains intact and 
undisturbed. 
Progress Check 
6. In the past, occupations that entailed exposure to asbestos included which 
of the following? 
 
A. construction workers, carpenters, sheet metal workers, and pipefitters 
B. utility workers, boiler makers, and electricians 
C. shipyard workers and automobile mechanics 
D. all of the above 
To review relevant content, see Past Occupational Exposure in this section. 
7. Of the following, who is most likely to be at risk of asbestos exposure? 
 
A. a child attending a school with asbestos-containing tile flooring 
B. an adult who uses vermiculite potting soil while gardening 
C. a person who resided with an asbestos worker in the 1940s 
D. a family living in a home with intact, solid asbestos-containing 
materials 
To review relevant content, see Direct Domestic Exposure and Exposure at 
School in this section. 
 
What Are the U.S. Standards for Asbestos Levels? 
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Upon completion of this section, you should be able to 
• explain the Occupational Safety and Health Administration 
(OSHA) permissible exposure limit (PEL) for asbestos. 
• explain the Environmental Protection Agency’s (EPA) 
maximum contaminant level (MCL) for asbestos in drinking 
water. 
Introduction The earliest evidence of asbestos-associated disease in workers 
was found in the 1930s by British studies (Lee and Selikoff, 
1979). We now know that the toxic effects of asbestos depend 
on the nature and extent of exposure, particularly on the 
• concentration of asbestos fibers involved in the exposure 
• duration of exposure 
• frequency of exposure 
• type of asbestos fibers involved in the exposure 
• dimensions and durability of the asbestos fibers 
United States government agencies (OSHA and Centers for 
Disease Control’s center National Institute for Occupational 
Safety and Health (NIOSH)) began establishing standards for 
asbestos in the 1970s. US regulatory agencies such as EPA and 
OSHA recognize six asbestos minerals (chrysotile, actinolite, 
tremolite, anthophyllite, amosite, crocidolite) as legally 
regulated forms of asbestos out of the group of asbestiform 
minerals. Asbestiform minerals are defined as crystal 
aggregates displaying these characteristics groups of 
separable, long, thin, strong, and flexible fibers arranged in 
parallel or in matted masses (ATSDR, 2001a). 
Other regulations focus primarily on the concentration of 
asbestos fibers in air. Currently, we have 
• a standard for asbestos in the workplace 
• a standard for asbestos in drinking water 
• regulatory requirements for school boards regarding 
asbestos in schools 
Occupational 
Standards 
In 1986, OSHA established the current permissible exposure 
limit (PEL) for asbestos in the workplace: 0.1 fibers/cc of air). 
PELs are an allowable exposure level in workplace air that are 
averaged over an 8-hour shift of a 40 hour workweek. 
OSHA requires employers of all workers who are exposed to 
asbestos (regardless of exposure level) to  
• provide training in the proper use of personal protective 
equipment (PPE) 
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• train workers in safety 
In addition, OSHA requires workers who are exposed to 
asbestos above the PEL and who are employed in certain 
asbestos industries to 
• use PPE 
• to undergo medical surveillance in order to identify those 
with signs of asbestos-associated disease, remove them 
from further exposure, and 
• provide documentation for work-related injury claims. 
Components of the required medical surveillance include 
• a standard questionnaire 
• a physical examination 
• a spirometric test 
• a chest X-ray. 
For further information about OSHA requirements, you can visit 
http://www.osha.gov/SLTC/asbestos/standards.html. 
For further information about protection guidelines, contact 




ATSDR does not consider the use of OSHA’s PEL for workplace 
exposures to be appropriate for environmentally exposed 
populations since residential and/or environmental exposures 
are 24 hours a day year round exposure rather than 8 hour day 
40 hour week exposures. Children and the elderly are also not 
exposed in the workplace. 
EPA has established a maximum contaminant level (MCL) for 
asbestos in drinking water: 7 MFL (million fibers per liter) in 
drinking water. 
In addition, EPA has 
• banned spraying of asbestos in building interiors (for 
fireproofing and ceilings)  
• regulated uses of asbestos in industrial products and 
construction  
• developed guidelines for proper treatment of in-place 
asbestos in old buildings  
• recommended “no visible emissions” of asbestos  
For more information on EPA rules and regulations regarding 
asbestos, visit the website at 
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http://www.epa.gov/oppt/asbestos. 
Schools The Asbestos in Schools Identification and Notification Act of 
1982 requires that local education agencies 
• inspect schools for friable material. 
• analyze these materials for asbestos content. 
• post results and notify parents and employees if 
asbestos is found. 
• maintain appropriate records. 
EPA also warned school authorities that power buffing and 
power stripping of asbestos-tile floors in schools produces 
significant airborne asbestos levels. Floor maintenance must be 
performed by hand to prevent release of asbestos fibers. 
• OSHA’s PEL for asbestos in the workplace is 0.1 
fibers/cc of air (8-hour TWA). 
Key Points 
• OSHA requires asbestos workers in certain industries to 
be trained in PPE; they must undergo medical 
surveillance if exposed above the PEL. 
• EPA’s MCL for asbestos in drinking water is 7 MFL 
(million fibers per liter) of drinking water. 
• Local education agencies must inspect schools and 
analyze friable material for asbestos content, 
communicate results, and maintain records. 
Progress Check 
8. OSHA's PEL for asbestos in the workplace is which of the following? 
 
A. 10 fibers/cc of air (8-hour TWA) 
B. 1 fiber/cc of air (8-hour TWA) 
C. 0.1 fibers/cc of air (8-hour TWA) 
D. 0.01 fibers/cc of air (8-hour TWA). 
To review relevant content, see Occupational Standards in this section. 
9. EPA's MCL for asbestos in drinking water is which of the following? 
 
A. 0.07 fibers per liter of drinking water 
B. 7 million fibers per liter of drinking water 
C. 700 fibers per liter of drinking water 
D. 70,000 fibers per liter of drinking water. 
To review relevant content, see Environmental Standards in this section. 
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What Is the Biologic Fate of Asbestos? 
Learning Objective Upon completion of this section, you should be able to 
• identify where asbestos fibers are most likely to be retained 
in the body  
Introduction Inhaled asbestos fibers enter the upper and lower respiratory 
tracts. The durability of the fibers in lung tissue may lead to a 
risk of disease.  
Penetration of 
Lungs 
Some of the inhaled asbestos fibers are deposited on the 
surface of the larger airways where some of them are cleared 
by mucociliary transport and swallowing. Other fibers are 
deposited further in the lung, especially in the bifurcations of 
the tracheobronchial tree and, eventually, in the alveolar sacs 
(Broaddus 2001).  
The dimensions of the asbestos fiber determines how easily 
and how far it penetrates the lungs and how quickly it is 
cleared. Wide fibers (diameter greater than 2 to 5 microns) 
tend to be deposited in the upper respiratory tract and cleared. 
Long thin asbestos fibers reach the lower airways and alveoli 
and tend to be retained in the lungs. However, it is important 
to remember that asbestos fibers of all lengths can induce 
pathological changes and cannot be excluded as contributors to 
asbestos-related diseases (Dodson . 2003et al ). 
Fate in Lungs In the lungs, asbestos fibers are subject to several lung 
defenses. 
• Mucociliary transport of the larger airways. This cleared 
material is usually swallowed and eliminated.  
• Dissolution by alveolar macrophages.  
• Attempted phagocytosis, resulting in fragmentation and 
splitting of fibers.  
• Encapsulation by proteins and deposition in ferrous material 
in a drumstick configuration called a ferruginous or 
asbestos body.  
The lymphatic system also clears fibers from the lungs (Dodson 
et al. 2003). Although some asbestos fibers are cleared from 
the lungs, most are retained in lung tissue for many years. The 
total burden of fibers in the lungs depends not only the size of 
the fiber but the amount of fibers inhaled from the environment 
(Dodson et al. 2003). 
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Movement Out of 
Lungs 
From the lungs, some asbestos fibers (mainly short fibers) can 
migrate to pleural and peritoneal spaces, especially following 
patterns of lymphatic drainage (Broaddus 2001). Their 
presence in the peritoneum is more likely if there is a high fiber 
burden in the lungs. 
Half-Life in the 
Lungs 
How rapidly the body’s defenses can clear asbestos fibers from 
the lungs depends in part on the type of asbestos. Amphibole 
fibers are retained longer than serpentine fibers of the same 
dimensions (Hillerdal 1999). Even so, all types of fibers are 
retained for many years in the lungs (2001a). 
Fate of Ingested 
Asbestos 
Most ingested asbestos fibers pass through the gastrointestinal 
tract unchanged and are cleared in the feces. A few ingested 
fibers pass through the walls of the gastrointestinal tract. Some 
of these fibers stay in the peritoneal cavity. Other of these 
fibers move into the bloodstream and into the kidneys, where 
some are eliminated unchanged in the urine.  
• Some inhaled asbestos fibers reach the lungs, where they 
become lodged in lung tissue, especially in the lower lung 
fields. 
Key Points 
• Some fibers are encapsulated in asbestos bodies. 
Some fibers move to pleural or peritoneal spaces or the 
mesothelium. 
• The half-lives of fibers vary, but they are retained for many 
years. 
• Ingested asbestos fibers are usually eliminated from the 
body. 
Progress Check 
10. Some inhaled asbestos fibers that reach the lungs 
A. become lodged and are retained in lung tissue 
B. migrate to other spaces 
C. are eliminated via phagocytosis 
D. all of the above 
To review relevant content, see Fate in Lungs and Movement Out of the Lungs and 
Fate of Ingested Asbestos in this section. 
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How Does Asbestos Induce Pathogenic Changes? 
Learning Objective Upon completion of this section, you should be able to 
• describe the three mechanisms by which scientists 
hypothesize asbestos induces pathogenic changes in the 
lungs. 
Introduction The three main determinants of asbestos toxicity are 
• fiber size, 
• durability, and 
• iron content. 
The presence of asbestos fibers in the lungs sets off a variety 
of responses leading to inflammation, cell and tissue damage, 
which can lead to disease related to fibrosis, or malignancy. 
The mechanisms by which asbestos causes disease are not fully 
understood. Currently, there are three hypotheses to account 
for asbestos’s pathogenicity 
• direct interaction with cellular macromolecules, 
• generation of reactive oxygen species, and 
• other cell-mediated mechanisms (especially inflammation) 




Because of their surface charge, asbestos fibers can adsorb to 
cellular macromolecules (proteins, DNA, RNA) and cell surface 
proteins. Binding of asbestos fibers to these cellular 
components is believed to induce changes in macromolecular 
conformation, thereby affecting protein function. 
Long asbestos fibers have been shown to interfere physically 
the mitotic spindle and cause chromosomal damage, especially 





The presence of asbestos fibers in lung and pleural tissue is 
also believed to cause the formation and release of reactive 
oxygen species (ROS). That is, when alveolar macrophages 
attempt to engulf and digest an asbestos fiber, they release 
ROS: hydrogen peroxide (H202), and the super oxide radical 
anion (O2-) (Kamp and Weitzman 1999, 1997). (H202), and the 
super oxide radical anion (O2-) (Kamp and Weitzman 1999, 
1997). Through the Haber-Weiss (or Fenton) reaction, these 
ROS react with each other to produce hydroxyl radicals, which 
are even more potent oxidizers. This reaction is believed to be 
catalyzed by iron present on the surface of the asbestos fibers 
(Broaddus 2001; ATSDR 2001). 
Page 30 of 73 
 
Agency for Toxic Substances and Disease Registry Asbestos Toxicity 





The presence of asbestos fibers also causes alveolar 
macrophages, lung cells, and pleural cells to release cellular 
factors (such as leukotrienes, prostaglandins, TNF-α ) that lead 
to multiple cellular processes such as 
• inflammation 
• macrophage recruitment 
• cell and DNA damage 
• cell proliferation 
• apoptosis 
The exact role of all these cellular processes in the formation of 
fibrosis and malignancy is still being defined (Broaddus 2001; 
Kamp et al. 2002). 
Primary Sites 
Affected 
All types of asbestos fibers tend to lodge in the lung at the 
bronchiolar-alveolar duct bifurcations, and some proceed to the 
smaller airways and alveolar sacs. From the lung, some fibers 
can migrate into the pleural space by unknown mechanisms 
(National Academy of Sciences, 2006). The length of time 
needed for migration and the number of fibers that successfully 
migrate may explain why asbestos-induced fibrosis occurs 
earlier in the lung than the more slowly developing pleural 
mesothelioma (Broaddus 2001). 
Carcinogenicity Asbestos has been designated a known human carcinogen as 
shown in the following table. All types of asbestos are 
carcinogenic, but some scientists believe that the amphibole 
type is more potent in causing mesotheliomas than the 
serpentine type (chrysotile). However, both types can cause 
mesotheliomas and are believed to be equally potent in causing 




International Agency for 
Research on Cancer (IARC) 
Known human carcinogen1 
U.S. Environmental 
Protection Agency (EPA) 
Known human carcinogenGroup A 
• The three processes hypothesized to account for asbestos’s 
pathogenicity are  
Key Points 
o direct interaction with cellular macromolecules 
o generation of reactive oxygen species (ROS) 
o other cell-mediated mechanisms (especially 
inflammation) 
• Asbestos induces pathological changes leading to such 
outcomes as fibrosis and malignancy. 
• Asbestos is genotoxic and carcinogenic. 
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Progress Check 
11. Asbestos induces pathogenic changes in lung tissue via: 
 
A. direct interaction with cellular macromolecules 
B. generation of active oxygen species 
C. cell-mediated inflammatory mechanisms 
D. all of the above 
To review relevant content, see Introduction in this section. 
12. As a result of its pathogenic actions, asbestos 
 
A. induces fibrotic changes in lung tissue 
B. is genotoxic 
C. is carcinogenic 
D. all of the above 
To review relevant content, see Introduction and Carcinogenicity in this 
section. 
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What Respiratory Conditions Are Associated with Asbestos? 
Learning Objective Upon completion of this section, you should be able to 
• describe the four respiratory conditions associated with 
asbestos exposure. 
Introduction According to the American Thoracic Society (2004), “asbestos 
has been the largest cause of occupational cancer in the United 
States and a significant cause of disease and disability from 
nonmalignant disease.” It has been estimated that the 
cumulative total number of asbestos-associated deaths in the 
United States may exceed 200,000 by the year 2030 
(Nicholson et al. 1982). 
Depending on the level of exposure, inhalation of asbestos 
fibers can cause different diseases such as 
• parenchymal asbestosis  
• asbestos-related pleural abnormalities 
• lung carcinoma 
• pleural mesothelioma 
Any combination of these syndromes (or all four of them) can 
be present in a single patient. Clinically, it is important to 
distinguish nonmalignant conditions from malignant diseases; 
differential diagnosis will be discussed further in later sections 
of this document. 
Parenchymal 
Asbestosis 
Parenchymal asbestosis is a diffuse interstitial fibrosis resulting 
from inhalation of asbestos fibers. Asbestos fibers inhaled deep 
into the lung parenchyma become lodged in the tissue, 
resulting in diffuse alveolar and interstitial fibrosis. The fibrosis 
first occurs in the respiratory bronchioles, particularly the 
subpleural portions of the lower lobes. The fibrosis can 
progress to include the alveolar walls. Fibrosis tends to 
progress even after exposure ceases (Khan et al. 2004). This 
fibrosis can lead to 
• reduced lung volumes 
• decreased compliance 
• impaired gas exchange 
• restrictive pattern of disease 
• obstructive features due to small airway disease 
• progressive exertional dyspnea with an insidious onset 
Parenchymal asbestosis is characterized by the following 
radiographic changes: fine, irregular opacities in both lung 
fields (especially in the bases) and septal lines that progress to 
honeycombing and sometimes, in more severe disease, 
obscuration of the heart border and hemi-diaphragm, the so-
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called shaggy heart sign (Khan et al. 2004). Radiographic 
changes depend on the duration, frequency, and intensity of 
exposure, however. 
Patients with parenchymal 
asbestosis may have elevated 
levels of antinuclear antibody 
and rheumatoid factors and a 
progressive decrease in total 
lymphocyte count with 
advancing fibrosis. 
Parenchymal asbestosis has no 
unique pathognomonic signs or 
symptoms, but diagnosis is 
made by the constellation of clinical, functional, and 
radiographic findings as outlined by the American Thoracic 
Society (American Thoracic Society 2004). These criteria 
include 
• sufficient history of exposure to asbestos  
• appearance of disease with a consistent time interval from 
first exposure  
• clinical picture such as insidious onset of dyspnea on 
exertion, bibasilar end-inspiratory crackles not cleared by 
coughing  
• functional tests showing restrictive (occasionally 
obstructive) pattern with reduced diffusing capacity  
• characteristic X-ray appearance  
• exclusion of other causes of interstitial fibrosis or 
obstructive disease such as usual interstitial pneumonia, 
connective tissue disease, drug-related fibrosis (American 
Thoracic Society 2004; Khan et al. 2004) 
The table below describes the natural history associated with 
parenchymal asbestosis. 
Parameter Typical Findings 
Sufficient exposures 
Usually associated with high-level occupational exposures (Khan 
et al., 2004). 
Radiographic changes: <20 years. 
Clinical manifestations: 20-40 years. 
Asbestosis appears earliest in those with the highest exposure 
levels (American Thoracic Society 2004) 
Latency periods 
Asbestosis develops in 49-52% of adults with occupational 
levels of asbestos exposure (Khan et al. 2004). 
Risk of asbestosis 
Increased risk for lung cancer and mesothelioma, though both 
can occur without parenchymal asbestosis (Weiss 1999; 
Co-morbid 
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conditions Hillerdal 1999) 
Severe asbestosis may lead to respiratory failure over 12-24 
years. Many patients with asbestosis die of other causes such as 
asbestos-associated lung cancer (38%), mesothelioma (9%), 




Asbestos-related pleural abnormalities (also called pleural 




• Pleural plaques 
• Benign asbestos pleural effusions 
• Diffuse pleural thickening 
• Rounded atelectasis (folded lung) 
The pleura are more sensitive to asbestos than the lung 
parenchyma, so the effects of asbestos exposure show here 
first and occur at much lower doses than the fibrotic changes in 
the lung (Peacock et al. 2000; Khan et al. 2004). 
Pleural plaques are well-
circumscribed areas of 
thickening, usually located 
bilaterally on the parietal 
pleura. They are usually 
asymptomatic, though they can 
cause small reductions in lung 
function (American Thoracic 
Society 2004). Pleural plaques 
are the most common 
manifestations of asbestos 
exposure; the highest rate 
(58%) is found in insulation 
workers (American Thoracic Society 2004; Peacock et al. 2000). 
The presence of pleural plaques in the general environmentally 
exposed population in developed societies is in the range of 
0.5%-8% (Khan et al., 2004). Indeed, they are considered a 
biomarker of asbestos exposure, depending on length from first 
exposure, rather than a threshold dose like asbestosis (Peacock 




• ceramic fibers 
• titanium 
• zeolite 
(Chapman et al. 2003; Rockoff and Robin 2002). 
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Benign asbestos pleural effusions are small unilateral effusions, 
often occurring as blood-stained exudates with various types of 
blood cells and mesothelial cells (Khan et al., 2004). These 
effusions are among the earliest manifestations of asbestos 
exposure; they can occur within 10 years of exposure 
(Chapman et al., 2003). They are usually asymptomatic. 
Rarely, they can cause pain, fever, and dyspnea. These 
effusions typically last for months, and may occasionally recur. 
Their presence can precede the occurrence of diffuse pleural 
thickening (Chapman et al. 2003). 
Diffuse pleural thickening is a noncircumscribed fibrous 
thickening of the visceral pleura with areas of adherence to the 
parietal pleura and obliteration of the pleural space. It can be 
associated with more extensive asbestos exposure than diffuse 
pleural plaques (Chapman et al. 2003). And, diffuse pleural 
thickening, in fact, has been reported to occur in 10% of 
patients with asbestosis (Khan et al. 2004). Diffuse pleural 
thickening can occur after benign pleural effusions. The fibrotic 
areas are ill-defined, involving costophrenic angles, apices, lung 
bases, and interlobar fissures. Diffuse pleural thickening can be 
associated with mild (or, rarely, moderate to severe) restrictive 
pulmonary function deficits such as decreased ventilatory 
capacity. When this occurs, the patient may experience 
progressive dyspnea and chest pain (Chapman et al. 2003; 
Rockoff et al. 2002). 
Rounded atelectasis (or folded lung) occurs when blebs of lung 
tissue are caught in bands of fibrous pleural tissue with in-
drawing of the bronchi and vessels (Khan et al. 2004). This 
produces a distinctive X-ray appearance: a rounded pleural 
mass with bands of lung tissue radiating outwards. This 
condition is usually asymptomatic, though some patients 
develop dyspnea or dry cough. The course is usually stable or 
slowly progressive. Folded lung is the least common asbestos-
related benign pleural disease, and it is not only associated with 
asbestosis exposure but can occur following other exposures 
and medical conditions. However, asbestos exposure is the 
leading cause of rounded atelectasis, accounting for 29%-86% 
of cases. It can rarely also co-occur with lung cancer 
(Stathopoulos et al. 2005). 
The differential causes of rounded atelectasis includes 
• exposure to mineral dusts such as asbestos, and 
occupational exposures to silica and mixed mineral dusts 
• exudative pleural effusions such as empyema, tuberculous 
effusions, hemothorax, post-cardiac surgery, chronic 
hemodialysis 
• other medical conditions such as Legionella pneumophilia 
pneumonia, histoplasmosis, end-stage renal disease, 
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pneumothorax, childhood cancer (Stathopoulos et al., 2005) 
The table below shows typical findings and natural history 








Parameter Pleural Plaques 
Typical exposures Can occur with 
short low level 
exposures or high 
level occupational 
exposures. The 
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Source: American Thoracic Society 2004; Chapman et al., 2003; Khan et al. 2004; 
Stathopoulos et al. 2005) 
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Lung Carcinoma Most lung cancers are associated with exposure to tobacco 
smoke. Smokers have a 13-fold higher risk than nonsmokers 
for lung cancer, and people with long-term passive exposure 
to tobacco smoke are at 1.5 times higher risk for lung cancer 
than are people who are never exposed to tobacco smoke. 
Lung cancer currently accounts for 28% of all cancer deaths in 
the United States (Minna 2005). 
Exposure to asbestos is associated with all major histological 
types of lung carcinoma (adenocarcinoma, squamous cell 
carcinoma, and oat-cell carcinoma). It is estimated that 4%-
12% of lung cancers are related to occupational levels of 
exposure to asbestos (Henderson et al. 2004). It is estimated 
that 20%-25% of heavily exposed asbestos workers will 
develop bronchogenic carcinomas (Khan et al., 2004). 
Whether asbestos exposure will lead to lung cancer depends 
on several factors 
• level, duration, and frequency of asbestos exposure 
(cumulative exposure) (Henderson et al. 2004) 
• time elapsed since exposure occurred 
• age when exposure occurred, 
• history of tobacco use 
• individual susceptibility factors not yet determined 
Most asbestos-related lung cancers reflect the dual influence of 
asbestos exposure and smoking (Henderson et al. 2004). 
Smoking and asbestos exposure have a multiplicative effect on 
the risk of lung cancer (Lee 2001; Henderson et al. 2004; 
ATSDR 2001). Asbestos as the sole contributing factor for an 
individual patient can be difficult to prove especially when the 
patient has other risk factors for lung cancer. The presence of 
parenchymal asbestosis is an indicator of high-level asbestos 
exposure, but lung cancer can occur without asbestosis. 
One of the best known sets of criteria to guide the clinician 
regarding whether asbestos contributed to lung cancer in an 
asbestos-exposed individual is the Helsinki criteria. For these 
criteria, some of the markers for attributing asbestos exposure 
as a contributing factor to lung cancer are 
• the presence of asbestosis – serves as marker for 
significant exposures to asbestos 
• 5,000 to 15,000 asbestos bodies per gram dry lung 
tissue (if lung biopsy indicated) 
• estimated cumulative exposure history of 25 fiber-years 
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to asbestos ( if known) 
• by history, 1 year of heavy occupational exposure or 5-
10 years of moderate exposure 
• lag time of 10 years since the first exposure 
The table below shows typical findings associated with lung 
carcinoma. 
Parameter Typical Findings 
Large cumulative exposure (short-term, high-level exposures 
or long-term, moderate-level exposures). 
Typical exposures 
Latency periods 20–30 years 
Only 5%-15% of patients are asymptomatic when diagnosed. 
Most present with cough, hemoptysis, wheeze, dyspnea 
(Minna, 2005). 
Clinical presentation 
Co morbid conditions 
Asbestosis, other asbestos-related diseases. Paraneoplastic 
syndromes associated with lung cancer. 
Same as lung carcinoma with other causes - 14% five year 





Diffuse malignant mesothelioma is a tumor arising from the 
thin serosal membrane of the body cavities, arising from the 
pleura, peritoneum, tunica vaginalis testis, and ovaries. It is a 
rare neoplasm, accounting for less than 5% of pleural 
malignancies. There are three histological types of malignant 
mesothelioma: epithelial, mixed, and sarcomatous. Of 
malignant mesotheliomas, 80% affect the pleura, and 20% of 
all malignant mesotheliomas affect the peritoneum (Khan et 
al. 2004). Peritoneal mesothelioma is discussed in the next 
section. 
In most cases, the tumor is rapidly invasive locally (Lee et al. 
2000). Patients with malignant pleural mesothelioma can have 
sudden onset of pleural effusion or thickening, dyspnea, and 
chest pain. By the time symptoms appear, the disease is most 
often rapidly fatal (British Thoracic Society 2001). 
Pleural mesothelioma is a signal tumor for asbestos exposure; 
other causes are uncommon. The risk of mesothelioma does 
depend on the amount of asbestos exposure (Weill et al. 
2004). All types of asbestos can cause mesothelioma, but 
some researchers believe that the amphibole form is more 
likely to induce mesothelioma than the serpentine form 
(ATSDR 2001a). 
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In 2000, about 3,000 people in the United States died of 
mesothelioma (Lee et al. 2000; Khan et al. 2004) According to 
the National Cancer Institute’s SEER data, there was an 
increase in the incidence of mesothelioma in the United States 
from the early 1970s to the mid-1990s, as disease developed 
in people exposed during peak asbestos exposure years 
(1940–1970). Mesothelioma incidence has probably started to 
decline in the United States, although it may still be increasing 
in Europe and Australia because of more abundant and 
prolonged use of asbestos in these countries than in the United 
States (Weill et al. 2004).  
The table below shows typical findings associated with pleural 
mesothelioma. 
Parameter Typical Findings 
Short-term, high-level exposures or chronic low-level 
exposures, especially to amphibole asbestos; incidence 
increases in dose-related manner (Hillerdal 1999). 
Typical exposures 
Latency periods 10–57 years (30–40 years typical). 
Frequently presents with chest pain accompanied by pleural 
mass or pleural effusion on chest X-ray (British Thoracic 
Society 2001). 
Clinical presentation 
High . The typical 1-year survival rate is <30%. 
Average survival time is 8–14 months after diagnosis (British 
Thoracic Society 2001). 
Mortality 
• Parenchymal asbestosis is a interstitial pulmonary fibrosis 
resulting from inhalation of asbestos fibers. It produces a 
restrictive pattern of disease and progressive exertional 
dyspnea. 
Key Points 
• Asbestos-related pleural abnormalities include pleural plaques, 
benign pleural effusions, diffuse pleural thickening, and 
rounded atelectasis. They are relatively benign conditions, 
though pleural thickening can cause restrictive deficits. 
• Lung carcinoma caused by asbestos exposure is histologically 
similar to lung cancer from other causes. 
• Malignant pleural mesothelioma is a rare tumor arising from 
the pleural mesothelium. It is a signal tumor for asbestos 
exposure. 
• Asbestos-associated respiratory diseases have long latency 
periods: 10 to 40 years or more, depending on the disease and 
exposure factors. 
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Progress Check 
13. Diffuse interstitial fibrosis resulting from inhalation of asbestos fibers and 
producing restrictive lung disease and progressive exertional dyspnea is 
termed 
 
A. lung carcinoma 
B. pleural mesothelioma 
C. parenchymal asbestosis 
D. asbestos-related pleural abnormalities 
To review relevant content, see Parenchymal Asbestosis in this section. 
14. Asbestos-related pleural abnormalities include which of the following? 
 
A. pleural plaques 
B. benign pleural effusions and diffuse pleural thickening 
C. rounded atelectasis 
D. all of the above 
To review relevant content, see Asbestos-Related Pleural Abnormalities in this 
section. 
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What Other Health Conditions Are Associated with Asbestos? 
Learning Objective Upon completion of this section, you should be able to 
• identify nonrespiratory conditions that might be associated 
with exposure to asbestos.  
Introduction Evidence suggests that exposure to asbestos might lead to 
conditions outside the respiratory system, including 
• peritoneal mesothelioma 
• other extrathoracic cancers 
• cardiovascular conditions secondary to pulmonary fibrosis 
Peritoneal 
Mesothelioma 
Peritoneal mesothelioma is similar to pleural mesothelioma 
except that it arises in peritoneal membranes. Like pleural 
mesothelioma, this tumor is rapidly locally invasive and often 
rapidly fatal after it is diagnosed. It is frequently asymptomatic, 
though it can often be detected by abdominal palpation as an 
expanding “doughy” feeling. 
Peritoneal mesothelioma is rare. In men, 90% of all 
mesotheliomas are pleural (Weill et al. 2004). In addition, the 
sex difference in incidence is smaller with peritoneal 
mesothelioma than for pleural mesothelioma (Hillerdal 1999). 
The table below shows male to female incidence ratios for the 
two different types of mesothelioma. 








Researchers and regulators have not been able to reach a 
consensus on the effects of asbestos on extrathoracic cancers. 
To address this concern, the National Academy of Sciences 
charged the Institute of Medicine (IOM) to review the state of 
the evidence regarding the role of asbestos in causing selected 
extrathoracic cancers. The results of this panel are presented 
below. 
Type of cancer Evidence for causality by asbestos 
Laryngeal  Sufficient 
Pharyngeal  Suggestive but not sufficient 
Stomach  Suggestive but not sufficient 
Colorectal  Suggestive but not sufficient 
Esophageal  Inadequate 
Source: (National Academy of Sciences, 2006) 
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Nevertheless, ATSDR and the National Toxicology Program 
(NTP) concur that it is prudent to consider increased risk of 
gastrointestinal cancer a possible effect of asbestos exposure 
(ATSDR 2001a; American Thoracic Society 2004). Screening for 
colon cancer is recommended for everyone over the age of 50, 
but on the basis of current evidence, screening for other 
extrathoracic cancers in people exposed to asbestos is not 
currently recommended (American Thoracic Society 2004; 
Griffith and Maloney 2003). 
Cardiovascular 
Conditions 
Cor pulmonale occurs in many forms of far advanced lung 
disease when fibrosis of the lungs leads to increased resistance 
to blood flow through the capillary bed. This condition is most 
commonly seen in patients with severe parenchymal 
asbestosis, though it can also occur with less severe fibrotic 
disease, especially if chronic obstructive pulmonary disease is 
simultaneously present, as is often the case with asbestos 
workers who smoke cigarettes. 
Constrictive pericarditis rarely occurs secondary to asbestos-
induced severe fibrosis or calcification of the pericardium.  
• Peritoneal mesothelioma is a rare, rapidly invasive 
tumor associated with asbestos exposure. 
Key Points 
• Asbestos exposure might be associated with 
extrathoracic cancers, especially colon cancer. This 
association is controversial. 
• Cor pulmonale can occur secondary to pulmonary 
fibrosis, mainly in patients with severe parenchymal 
asbestosis. 
• Rarely, constrictive pericarditis can occur secondary to 
asbestos-associated disease. 
Progress Check 
15. Exposure to asbestos is associated with 
 
A. peritoneal mesothelioma 
B. gastrointestinal cancer 
C. other extrathoracic cancers 
D. all of the above 
To review relevant content, see Peritoneal Mesothelioma in this section. 




B. constrictive pericarditis 
C. cor pulmonale 
D. all of the above 
To review relevant content, see Cardiovascular Conditions in this section. 
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How Should Patients Exposed to Asbestos Be Evaluated? 
Learning 
Objectives 
Upon completion of this section, you should be able to 
• identify the primary focuses of the exposure history and 
medical history 
• describe the most typical finding on patient examination 
Introduction Patients who have been exposed to asbestos should undergo a 
thorough medical evaluation. Early and accurate diagnosis is 
important to your choosing the most appropriate care 
strategies, even if the patient is not exhibiting symptoms. In 
cases of asbestos exposure, medical evaluation should include 
• an assessment of clinical presentation 
• an exposure history (See ATSDR Case Study in 
Environmental Medicine: Taking an Exposure History) 
• a medical history 
• a physical examination 
• a chest radiograph and pulmonary function tests 
This section focuses on the first four items, which are typically 
conducted during the patient’s visit to your office. 
Recommended tests are discussed in the next section. 
Clinical 
Presentation 
Many people with occupational exposure to asbestos never 
have serious asbestos-related diseases. However, asbestos-
associated diseases typically have long latency periods, so 
many patients exposed to asbestos are asymptomatic for years 
before asbestos-related any disease develops. If and when 
asbestos-associated disease does manifest clinically, the 
patient’s symptoms depend on the type and stage of disease(s) 
involved (see table). A single patient can have any combination 
of asbestos-associated diseases. 
Asbestos-Associated Disease Clinical Presentation 
Parenchymal asbestosis Presenting Symptoms 
• Insidious onset of dyspnea on exertion 
• Fatigue 
Advanced Stages 
• Clubbing of the fingers 
• Cor pulmonale (rare) 
Asbestos-related pleural abnormalities Presenting Symptoms 
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• Usually none 
Diffuse Pleural Thickening 
• Progressive dyspnea 
• Intermittent chest pain 
Rounded Atelectasis 
• Dyspnea 
• Dry cough 
Lung cancer Presenting Symptoms 
• Early in the course, usually none 
• Occasionally, dry cough 
Advanced Stages 
• Hemoptysis 
• Chest pain 
• Weight loss 
• Fatigue 
• Dyspnea with pleural effusion 
Mesothelioma Presenting Symptoms 
• Early in the course, can be asymptomatic 




• Severe and progressive chest pain 
• Pleuritic chest pain 
• Systemic signs of cancer such as weight 
loss and fatigue 
Source: British Thoracic Society 2001; American Thoracic Society 2004
Exposure History Taking a detailed exposure history is an important step in 
evaluating a patient who may be at risk for developing 
asbestos-associated diseases. In general, risk of asbestos-
related disease increases with total dose (Khan et al. 2004). 
However, since asbestos accumulates in the body, even 
relatively minor exposures many years before could be 
important in diseases like mesothelioma. The exposure history 
should include the following information 
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• work history, including occupations in which the patient 
may have been exposed directly or indirectly 
• source, intensity, frequency and duration of exposure 
• time elapsed since first exposure 
• if extant, workplace dust measurements or cumulative 
fiber dose (or exposure scenario, if levels cannot be 
determined) 
• use of personal protective equipment 
• other sources of exposure, including paraoccupational 
exposures from family members and other household 
contacts 
• sources of environmental exposure including a residence 
near an area with naturally occurring asbestos deposits or 
hobbies or recreational activities that involve materials that 
are contaminated with asbestos) 
• sources of other environmental contaminants such as 
environmental tobacco smoke  
For more information on the exposure history, see the Taking 
an Exposure History CSEM at 
http://www.atsdr.cdc.gov/csem/exphistory/ . 




Typical Exposure History 
Parenchymal 
asbestosis 
Usually associated with high-level occupational exposures, not 





Presence depends on time from exposure, not a threshold 
dose. The incidence of this disorder in a population does 
increase with exposure. Occurs in 0.5% to 8% of 
environmentally exposed individuals to a high of 58% in 
insulation workers (Peacock et al. 2000).  
Lung cancer Large cumulative exposure. It is believed to be dose-related.  
Mesothelioma Not as dose-related as other asbestos-related diseases, but the 
risk does increase with dose. Can be found in residents near 
asbestos mines and with paraoccupational exposure. The 
percent of patients with confirmed asbestosis will die of 
mesothelioma (British Thoracic Society 2001). 
Medical History Knowing the complete medical history of a patient who has 
been exposed to asbestos is important to making an accurate 
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diagnosis. It is especially important to ask about a history of 
smoking and exposure to second-hand smoke, because 
exposure to tobacco smoke, especially active smoking, can 
greatly increase a patient’s risk of lung cancer and can worsen 
the effects of parenchymal asbestosis. 
In addition, it is important to be aware of other respiratory and 




Patients with a history of asbestos exposure should receive a 
full physical examination. In the case of early or mild disease, 
there will probably be no abnormal physical findings. The most 
common abnormal finding with significant asbestosis is 
bibasilar rales with end-inspiratory crackles on pulmonary 
auscultation. These are typically described as sounding like 
Velcro (Ross 2003). 
Physical examination should also include 
• abdominal palpitation, which is used to detect the 
expanding “doughy” feeling associated with peritoneal 
mesothelioma. 
• digital exam for clubbing of the fingers and cyanosis 
(American Thoracic Society 2004). 
• examination of the extremities for symmetrical dependent 
edema, one of the physical findings of cor pulmonale. 
Differential 
Diagnosis 
Several treatable conditions have symptoms similar to those of 
asbestos-associated diseases. For this reason, it is important to 
distinguish between these conditions and such disorders as 
parenchymal asbestosis (see table), which is not curable 
(treatment is supportive and symptomatic). 
It is also important to distinguish between benign asbestos-
associated conditions and malignant conditions such as lung 
cancer and mesothelioma. In cases that are not clear cut, a 








Differential Diagnosis: Respiratory 
Conditions 
• idiopathic pulmonary fibrosis • rheumatoid arthritis Parenchymal 







• interstitial pulmonary fibrosis (IPF) 
• left ventricular 
failure (presents 
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• hypersensitivity pneumonitis with dyspnea, rales, 
edema, restriction, 
and basilar 
markings on chest 
film) 
• sarcoidosis 
• chronic obstructive pulmonary 
disease (may produce rales similar 
to bibasilar rales) 
• drug-related fibrosis 





Single pleural plaques 
• malignant mesotheliomas and 
metastatic adenocarcinomas (Khan 
et al. 2004) 
Single calcified pleural plaques 
• tuberculosis 
• empyema 
• hemothorax (Khan et al. 2004) 
Bilateral calcified pleural plaques 
• Most commonly asbestos related 
but in rare cases  
o radiation exposure 
o hyperparathyroidism 
o pulmonary infarction 
o pancreatitis (Khan et al. 
2004) 
Diffuse pleural thickening 
• post-exudative effusions such as 
parapneumonic effusions and those 
secondary to connective tissue 
disease 
• hemothorax 
• mesothelioma, (Khan et al. 2004) 
Rounded atelectasis (folded lung) 
• Lesions that are similar to in 
appearance to rounded 
atelectasis (i.e.. , solitary 
pulmonary mass) are  
o Malignancies such as 
bronchogenic carcinoma, 
metastasis, lymphoma 
o Benign neoplasms such 
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as hamartoma and 
adenoma 





o Infections such as 
tuberculosis, round 
pneumonia, fungal 
infections (Khan et al., 
2004) 
 Lung carcinoma Other causes of a solitary pulmonary 
nodule 
• Folded lung 
• Metastatic lesion 
• Lymphoma 
• Benign neoplasms such as 
hamartoma or adenoma 
• Vascular lesion such as a 
arteriovenous malformation, 
pulmonary infarction or 
hematoma 
• Infectious lesions from 
tuberculosis, fungal infections 
(Khan et al. 2004) 
• Diffuse pleural thickening Malignant 
mesothelioma • Metastatic adenocarcinoma 
(Khan et al. 2004; British 
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Key Points • The exposure history focuses on finding information on 
exposures to asbestos. 
• The medical history focuses on smoking history and other 
respiratory conditions. 
• The most typical abnormal finding on examination of 
patients with a history of asbestos exposure is bibasilar end 
inspiratory rales on pulmonary auscultation. 
• Patients with parenchymal asbestosis present to the 
clinician with the chief complaint of fatigue, insidious onset 
of dyspnea on exertion. 
• Asbestos-related pleural abnormalities typically do not 
cause symptoms, although some patients experience 
progressive dyspnea and chest pain. 
• Lung cancer can be asymptomatic, but in the later stages 
patients experience fatigue, weight loss, chest pain, 
dyspnea, or hemoptysis. 
• Mesothelioma is typically asymptomatic until later stages, at 
which point patients have dyspnea and chest pain. 
Progress Check 
17. The most typical abnormal finding on physical examination of a patient 
with significant asbestosis is 
A. a “doughy” feeling in the abdomen 
B. bibasilar inspiratory rales on pulmonary auscultation 
C. clubbing of the fingers 
D. all of the above 
To review relevant content, see Physical Examination in this section. 
18. Why is it important to know a patient's exposure history? 
A. Asbestos-associated diseases have symptoms similar to those of 
treatable diseases, and the exposure history assists a differential 
diagnosis. 
B. Activities such as smoking can increase a patient’s risk of asbestos-
related diseases. 
C. Asbestos accumulates in the body and, for certain disorders, even 
minor exposures can be important. 
D. all of the above 
To review relevant content, see Exposure History in this section. 
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What Tests Can Assist with the Diagnosis of Asbestos Toxicity? 
Learning 
Objectives 
Upon completion of this section, you should be able to 
• describe pulmonary function test findings associated with 
parenchymal asbestosis 
• describe chest radiograph findings associated with other 
asbestos-associated diseases. 
Introduction The two most important tests in diagnosing asbestos-
associated disease are 
• pulmonary function tests, and 
• chest radiographs. 
Other tests and procedures that are sometimes used to 
diagnose asbestos-associated diseases by specialists in cases 
that require further work-up are 
• computed tomography (CT) or high-resolution computerized 
(axial) tomography (HRCT) 
• bronchoalveolar lavage (BAL) 
• lung biopsy 
• blood studies 




Screening pulmonary function tests are useful for finding 
restrictive deficits associated with parenchymal asbestosis (see 
table). Findings may include a reduction in forced vital capacity 
(FVC) with a normal Forced Expiratory Volume (FEV1)/FVC 
ratio. Some sources report abnormal pulmonary function tests 
in 50% to 60% of patients with asbestosis (Ross 2003). 
In some cases, combined patterns of restrictive and obstructive 
disease may be seen. For further assessment of whether a 
patient has a restrictive abnormality and asbestosis, additional, 
more specialized tests may be required 
• Carbon monoxide diffusion capacity (DLco), which is very 
sensitive to the ventilation-perfusion mismatch and gas 
exchange abnormalities characteristic of all types of diffuse 
interstitial pulmonary fibrosis and DLco is reduced in 70% 
to 90% of asbestosis cases (Ross 2003). Be aware however 
that, although fairly sensitive, the DLco is a non-specific 
finding and it can be reduced in far advanced stages of 
COPD as well as in other types of restrictive interstitial 
diseases. 
• static lung volumes 
• plethysmographic and helium dilution methods 
Page 51 of 73 
 
Agency for Toxic Substances and Disease Registry Asbestos Toxicity 
Case Studies in Environmental Medicine (CSEM) 
 
Consider consulting a pulmonologist if the diagnosis is unclear, 
if there is a rapid decline in pulmonary function, or if there is a 
need for a tissue biopsy or BAL, such as in cases where lung 
cancer, mesothelioma, or an infection is suspected. The 
pulmonologist may recommend more extensive pulmonary 
function tests.  
Asbestos-Associated Disease Pulmonary Function Test Findings 
• reduction in FVC, normal FEV1/FVC ratio. Parenchymal asbestosis 
• a 25% to 74% reduction of forced 
expiratory rate 
• restrictive pattern with a decreased DLco 
• mixed obstructive/restrictive pattern 
(reduced FEV1/FVC associated with 
reduced FEV1) (American Thoracic 
Society 2004) 
• reduced FVC can be associated with 
diffuse pleural thickening 
Asbestos-related pleural 
abnormalities 
Chest Radiograph The chest radiograph is used primarily to 
• find structural changes associated with asbestos-associated 
diseases such as asbestosis 
• assess asbestos-associated parenchymal and pleural 
disease such as pleural plaques and mesothelioma. 
Diagnosis of asbestosis should mostly but not totally be based 
on radiographic findings, per the diagnostic criterion of the 
American Thoracic Society. In 10% to 15% of cases, an 
asbestos-associated pulmonary function abnormality can occur 
without definite radiologic change (Ross 2003). The 
association of pleural thickening and calcification with 
interstitial changes enhances diagnostic accuracy of 
asbestosis. The American Thoracic Society includes 
radiographic findings as one of their criterion for making a 
diagnosis of asbestosis. 
In 1980, the International Labour Organization (ILO) 
developed a system for radiographic classification of the 
pneumoconiosis. Persons certified to use this rating system are 
called “B readers.” A current list of B readers can be found at 
http://www.cdc.gov/niosh/topics/chestradiography/breader-
list.html. Detection of parenchymal asbestosis by chest 
radiography should be guided by the ILO system or other 
standard reading methods. 
A list of typical chest radiograph findings for each of the 
asbestos-associated diseases is in the table below. 
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Typical Chest Radiograph Findings 
• small, irregular opacities in one or both lung fields, with a 
pattern of irregular linear opacities 
Parenchymal 
asbestosis 
• diffuse, bilateral interstitial fibrosis 
• with advanced disease, “ground-glass” appearance that blurs 
the heart border if there is combined interstitial and pleural 
involvement (also known as the “shaggy heart sign”) 






• often multiple bilateral well-circumscribed areas of thickening 
found on the pleura, sometimes with calcification (10%-15%) 
(Khan et al. 2004) 
Benign Pleural Effusions 
• cloudy, milky appearance like other pleural effusions 
Diffuse Pleural Thickening 
• thickening of the parietal pleura on more than one quarter of 
the chest wall appears as a lobulated prominence of the 
pleura adjacent to the thoracic margin (Khan et al. 2004) 
• thickening of the visceral pleura (diffuse, may also appear as 
interlobar fissure pleural thickening) 
Rounded Atelectasis  
• appears as a rounded pleural mass with bands of lung tissue 
radiating outwards 
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• radiological appearance same as that of lung cancers with 
other causes, (i.e., solitary pulmonary mass with or without 
mediastinal lyphadenopathy) 
Lung cancer 
Mesothelioma May present as a  
• pleural effusion 
• pleural mass 
• a diffuse pleural thickening 
CT and HRCT In some cases, CT and HRCT scans can facilitate diagnosis of 
asbestos-associated diseases. Because they are associated with 
higher doses of radiation than conventional chest X-rays and 
their cost-effectiveness and efficiency as screening tools have 
not been established, CT scans should not be used for routine 
screening. They can be useful in further investigating 
abnormalities found on chest X-rays and in detecting 
abnormalities not seen on chest films of patients with dyspnea or 
pulmonary function abnormalities.  
CT and HRCT scans are more sensitive than chest radiographs. 
When B readers are not able to agree on the presence of 
asbestos-associated disease per the chest radiograph, CT and 
HRCT scans can be used (American Thoracic Society 2004). They 
are especially useful in detecting 
• early changes of parenchymal asbestosis.  
• pleural disease, such as plaques and rounded atelectasis 
• the difference between asbestos-associated pleural 
plaques and soft tissue densities 
• mesothelioma (British Thoracic Society 2001). 
ATSDR recommends low-dose CT scans for screening certain 
former vermiculite miners or vermiculite mill workers and their 
household contacts whose chest radiographs are indeterminate 
(Muravov et al. 2005).  
The utility of other imaging techniques such as ultrasound, 
gallium scanning, magnetic imaging, ventilation-perfusion 
studies, and positron emission tomography has not been 
established. New digital imaging techniques (e.g., digital 
radiography) are under development as well. 
BAL and Lung 
Biopsy 
BAL (bronchoalveolar lavage) is sometimes used by specialists to 
identify other possible causes for lung pathology and it can be 
used to determine the level of exposure to asbestos by 
measuring the amount and type of asbestos bodies in the lung 
tissue and lavage fluid (Santorelli et al. 2001; American Thoracic 
Society 2004). Special laboratory facilities for quantitating 
asbestos fibers must be available. 
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Lung biopsy is a definitive test used in the histopathical 
confirmation of asbestos-associated diseases. Lung biopsies are 
rarely used to diagnosis asbestosis or pleural plaques, because 
diagnosis of these conditions is usually based on findings from 
the medical evaluation and other tests. Appropriate referral to a 
specialist is indicated if lung cancer or mesothelioma is 
suspected, since a lung biopsy may be indicated under these 
conditions. 
Blood Studies Arterial blood gas (ABG) and pulse oximetry are sometimes used 
to detect decreases in oxygen in the blood associated with the 
respiratory changes associated with asbestos-related disease. 
Blood chemistry studies may occasionally be useful for ruling out 
other causes of restrictive lung disease (e.g., rheumatoid lung 
disease, uremia, increased sedimentation rate). 
Colon Cancer 
Screening 
Some studies show that asbestos exposure increases a patient’s 
risk for colon cancer. Therefore, colon cancer screening should 
be considered in accordance with the American Cancer Society’s 
screening guidelines for colon cancer for people over age 50 




It is important to know what other conditions bear radiographic 
similarities to changes associated with asbestos-related disease 
(see table). 
Asbestos-Associated Disease Similar Radiographic Appearance 
• left ventricular failure Parenchymal asbestosis 
• other treatable and non-treatable forms of 




General differential diagnoses 
• acute pleuritis (due to conditions such as 
empyema and tuberculosis)  
• previous surgery or chest wall trauma 
• past empyema or infected pleural effusion 
Pleural plaques may be confused with 
• extra pleural fat 
• muscle or fat shadows 
• pleural thickening from old rib fractures 
Benign asbestos pleural effusions may be confused 
with 
• Malignant pleural effusion 
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• Multiple other causes of pleural effusion, 
including tuberculosis, congestive heart failure 
Diffuse pleural thickening may be confused with 
• Mesothelioma 
• Healed empyema 
• Old chest trauma 
• Old chest surgery 
Rounded atelectasis 
• Bronchogenic carcinoma 
• Mesothelioma. 
• Pleural-based lung cancer or metastasis to the 
pleura 
Lung cancer Lung cancer not related to asbestos. 




To help attribute pulmonary fibrosis to asbestos exposure check 
for the diagnostic guidelines suggested by the American 
Thoracic Society 
• appropriate exposure history,  
• appropriate latency period between exposure and onset of 
symptoms 
• characteristic chest radiograph appearance when the ILO 
system of either parenchymal or pleural changes is used. 
Other findings that aid in attributing a disease to asbestos 
exposure include 
• asbestos bodies and uncoated fibers in the lungs found on 
BAL (if performed) 
• restrictive pattern and decrease in DLco on spirometry 
• ausculatory signs such as characteristic rales (Holland and 
Smith 2003; American Thoracic Society 2004). 
Bilateral calcified pleural plaques are usually attributed to 
asbestos exposure, but single-sided pleural plaques may not be 
and a search for other causes such as old tuberculosis, 
empyema, or hemithorax may be indicated. CT scanning can be 
used to make a definite diagnosis of rounded atelectasis, if 
there are any questions (Khan et al. 2004). 
As stated previously, sets of diagnostic criteria like the Helsinki 
criteria can help determine if a lung cancer has any causal 
relationship to asbestos exposure. 
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Malignant mesotheliomas are, for all practical purposes, related 
to previous asbestos exposure.  
• Parenchymal asbestosis is associated with a reduction in 
FVC and restrictive patterns on spirometry. 
Key Points 
• Signs of parenchymal asbestosis on chest X-ray include 
irregular opacities, interstitial fibrosis, and the “shaggy 
heart sign.” 
• On chest X-ray, pleural plaques appear as well-
circumscribed areas of pleural thickening, sometimes with 
calcification. 
• On chest X-ray, pleural effusions have a cloudy or milky 
appearance. 
• On chest X-ray, diffuse pleural thickening appears as a 
lobulated prominence and interlobar fissure thickening. 
• On chest X-ray, findings associated with rounded atelectasis 
appear as a rounded pleural mass with radiating bands of 
lung tissue. 
• Asbestos-associated lung cancer has the same appearance 
as lung cancer from other causes. 
• Chest X-ray findings associated with mesothelioma include 
pleural effusions or a pleural mass. 
• CT and HRCT scans can be useful in diagnosing early 
changes associated with asbestosis, in helping clarify 
questionable pleural or parenchymal findings and in 
diagnosing mesothelioma. 
• Other tests that can be useful include BAL, lung biopsy, and 
colon cancer screening. 
Progress Check 
19. The two most important tests for diagnosing asbestos-associated 
diseases are 
 
A. BAL and lung biopsy 
B. CT and HRCT scans 
C. chest radiograph and pulmonary function tests 
D. blood studies and colon cancer screening. 
To review relevant content, see Introduction in this section. 
20. Diffuse, bilateral interstitial fibrosis and small, irregular opacities are 
characteristic X-ray findings with 
 
A. parenchymal asbestosis 
B. lung cancer 
C. mesothelioma 
D. all of the above 
To review relevant content, see Chest Radiograph in this section. 
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How Should Patients Exposed to Asbestos Be Managed and Treated? 
Learning 
Objectives 
Upon completion of this section, you should be able to: 
• identify two primary strategies for managing asbestos-
associated diseases. 
• describe specific strategies for managing parenchymal 
asbestosis. 
Introduction In general, asbestos-associated diseases such as asbestosis and 
pleural plaques are not treatable. Management focuses on 
prevention and amelioration of symptoms whether the patient is 
asymptomatic or already ill. Therefore, the primary goals are to 
• remove the patient from the workplace or source of exposure (if 
possible) or provide proper respiratory protection according to 
OSHA standards 
• in states, where asbestosis is a reportable disease, report new 
cases to the appropriate health authorities. 
• monitor the patient to facilitate early diagnosis of any treatable 
respiratory conditions 
Patients who are symptomatic may need documentation of 
impairments caused by asbestos-associated disease for the purpose 
of filing for worker compensation, social security disability, or other 
claims. Degree of disability should be stated in the terms required 
by the program to which the patient is applying. Recording these 
impairments is an important task and may require the assistance of 
a specialist. To locate a specialist, please refer to the Web resources 
listed under Where Can I Find More Information? at the end of this 
CSEM 
The remainder of this section focuses on patient care. 
All Exposed 
Patients 
Care of patients who have been exposed to asbestos, whether or 
not they are symptomatic, involves routine follow up to facilitate 
early diagnosis and intervention. This includes 
• taking exposure and medical histories and regular physical 
examinations 
• periodic chest X-rays and pulmonary function tests to look for 
early signs of asbestos-associated disease 
• gathering information on smoking cessation 
• educating patients regarding the possible consequences of 
asbestos exposure 
Information and Instructions for Patients
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 Parenchymal asbestosis is irreversible, and the rate of disease 
progression varies (American Thoracic Society 2004). Currently, 
there is no effective treatment. Patients with advanced disease and 
hypoxemia at rest, during exercise, or during sleep will benefit from 
continuous home oxygen therapy, which can prevent or attenuate 
cor pulmonale. However, primary management strategies for 
parenchymal asbestosis are listed below 
Parenchymal 
Asbestosis 
• remove the patient from the source of exposure (if possible) or 
provide personal protective equipment to OSHA standards 
• notify employer of exposures to asbestos so that medical 
surveillance and personal protective equipment can be instituted 
(if occupational exposure). 
• in states, where asbestosis is reportable, notify the appropriate 
health authorities 
• assess the patient’s level of disability 
• treat respiratory infections aggressively. 
• provide annual influenza and regular pneumococcal vaccines at 
intervals recommended by CDC 
• provide respiratory therapies and pulmonary rehabilitation as 
needed 
• counsel patients who smoke to quit. 
• follow the general strategies listed for all patients 
Patients should be monitored periodically (per doctor-patient 
consultation) for disease progression and closely observed for 
asbestos-associated malignancies such as lung cancer, 




Pleural plaques are benign, but they can occasionally result in 
pulmonary impairment. In addition, patients with asbestos-related 
pleural abnormalities are likely to have or eventually get 
parenchymal asbestosis or asbestos related cancers. Therefore, 
management of asbestos-related pleural abnormalities involves 
monitoring for parenchymal asbestosis and the general strategies 
listed for all patients. 
Mesothelioma Diffuse malignant mesothelioma is almost always fatal. According to 
the British Thoracic Society, the mean life expectancy following 
diagnosis is 8 to 14 months (British Thoracic Society 2001).  
For more information about the diagnosis and treatment of 
mesothelioma, see: 
• British Thoracic Society’s Standards of Care Committee, 
Statement on malignant mesothelioma in the United Kingdom 
(Thorax 2001; 56:250-265) 
• The National Cancer Institute’s latest news on the treatment of 
mesothelioma at URL 
http://www.nci.nih.gov/cancertopics/types/malignantmesothelio
ma/ 
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Lung Cancer The treatment and management of asbestos-associated lung cancer 
is the same as that of lung cancer from other causes. 
• The two primary strategies for managing asbestos-associated 
diseases are  
Key Points 
o Remove the patient from further exposure to asbestos (if 
possible) or provide of personal protective equipment up 
to OSHA standards.  
o Monitoring the patient carefully to facilitate early 
diagnosis of treatable complications. 
• The primary strategies for managing parenchymal asbestosis 
are to stop exposure, stop smoking, avoid or aggressively treat 
respiratory infection, and assess the level of impairment. 
• Notify employer of exposure so that medical surveillance and 
appropriate PPE can be provided (if occupational exposures are 
over OSHA standards). 
Progress Check 
21. Primary strategies for managing asbestos-associated diseases in exposed 
patients or those already ill include 
 
A. smoking cessation 
B. periodic pulmonary function tests 
C. patient education 
D. all of the above 
To review relevant content, see Introduction in this section. 
22. Managing parenchymal asbestosis involves: 
 
A. smoking cessation 
B. regular influenza and pneumococcal vaccines 
C. respiratory therapies and pulmonary rehabilitation 
D. all of the above 
To review relevant content, see Parenchymal Asbestosis in this section. 
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What Instructions Should Be Given to Patients? 
Learning Objective Upon completion of this section, you should be able to 
• list four instructions for patient self-care and two 
instructions for clinical follow-up. 
Introduction Patients with a history of asbestos exposure will vary widely in 
their clinical condition. Some will be asymptomatic and will 
continue to be so for life. Some will be beginning to show signs 
of asbestos-associated disease, and others will have more 
established disease. The care you provide will depend on the 
clinical status of the patient. All patients exposed to asbestos, 
however, need some basic guidance on 
• self-care, so they can minimize further risks and avoid 
complications to the extent possible 
• clinical follow up, so they understand when and why to 
return for further medical attention. 
ATSDR has developed a patient education sheet on asbestos 
toxicity.  
Self Care Patients should be advised to avoid exposures and conditions 
that might further increase their risk of disease or worsen their 
existing condition (see table). 
Advice Rationale 
If the patient smokes, advice them to 
stop smoking and provide advice on 
smoking cessation. All patients should 
avoid exposure to second-hand smoke. 
Smoking decreases lung defenses, 
dramatically increases risk of lung cancer in 
case of asbestos exposure, and worsens 
effects of asbestosis. 
Avoid exposure to respiratory irritants, 
such as air pollution, dusts, and fumes. 
These irritants can worsen breathing 
problems. 
Respiratory infections can be very serious in 
people with asbestos-associated respiratory 
conditions. 
Avoid exposure to respiratory 
infections. 
Clinical Follow Up Patients should be advised to consult their physicians if they 
have 
• any sign or symptom of respiratory infection 
• signs or symptoms of other health changes (especially those 
possibly related to an asbestos-associated disease). 
ATSDR’s patient education sheet on asbestos toxicity has a more 
detailed checklist that you can use to determine which types of 
follow-up are relevant for a given patient. 
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Key Points Counsel patients as follows: 
• if smoking, patients should stop  
• avoid other respiratory irritants 
• avoid exposure to respiratory infections 
• contact their physician if you have a respiratory infection or 
other health changes 
• use the patient education sheet and prescribed follow up 
check list on asbestos toxicity at 
http://www.atsdr.cdc.gov/csem/asbestos/pated_sheet2.html 
Progress Check 
23. Patients who were exposed to asbestos should 
 
A. stop smoking 
B. avoid exposure to other respiratory irritants 
C. avoid exposure to respiratory infections and contact their doctor if they 
D. develop signs of infection or other health changes 
all of the above 
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Where Can I Find More Information? 
For More 
Information 
Please refer to the following Web resources for more 
information on the adverse effects of asbestos, the treatment 
of asbestos-associated diseases, and management of persons 
exposed to asbestos. You may also contact ATSDR (see URLs 
provided below), your state and local health departments, and 
university medical centers.  
Independent Medical Examiners: 
http://www.abime.org/  
Association of Occupational and Environmental Clinics: 
http://www.aoec.org
American College of Occupational and Environmental Medicine:  
http://www.acoem.org
American College of Medical Toxicologists: 
http://www.acmt.net
American College of Preventive Medicine: 
http://www.acpm.org
NIOSH Certified B-Readers National Listing: 
http://origin.cdc.gov/niosh/topics/chestradiography/breader-
list.html
Occupational Safety and Health Administration: 
http://www.osha.gov
ATSDR Information Center: 
http://www.atsdr.cdc.gov/icbkmark.html




For further information on asbestos-associated diseases, please 
refer to 
American Thoracic Society. 2004. Diagnosis and initial 
management of nonmalignant diseases related to asbestos. 
American Journal of Respiratory and Critical Care Medicine, 
170: 691-715, 2004. 
British Thoracic Society Standards of Care Committee. 2001. 
Statement on malignant mesothelioma in the United Kingdom. 
Thorax 56: 250-265. 
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Peipins LL, Campolucci S, Lybarger JA, et al. 2003. 
Radiographic abnormalities and exposure to asbestos-
contaminated vermiculite in the community of Libby, Montana. 
Environmental Health Perspectives Environ Health Perspect. 
111(14):1753-9
Other CSEMs Case Studies in Environmental Medicine: Asbestos is one 
educational case study in a series. To view Taking an Exposure 
History and other publications in this series, please go to 
http://www.atsdr.cdc.gov/csem/csem.html 
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Introduction ATSDR seeks feedback on this course so we can assess its 
usefulness and effectiveness. We ask you to complete the 
assessment questionnaire online for this purpose. 
If you complete the Posttest online, you can receive continuing 
education credits as follows: 
 
Accrediting Organization Credits Offered 
Up to 2.0 hours in category 1 credit toward the 
American Medical Association (AMA) Physician's 
Recognition Award 
Accreditation Council for Continuing 
Medical Education (ACCME) 
American Nurses Credentialing 
Center (ANCC), Commission on 
Accreditation 
2.0 contact hours 
National Commission for Health 
Education Credentialing, Inc. 
(NCHEC) 
2.0 Certified Health Education Contact Hours 
(CECH) 
International Association for 
Continuing Education and Training 
IACET ) 
0.2 continuing education units (CEUs) 
( 
 
Instructions To complete the Assessment and Posttest, go to 
http://www2.cdc.gov/atsdrce and follow the instructions on 
that page. You can immediately print your continuing 
education certificate from your personal transcript online. No 
fees are charged. 
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Posttest 1. What Is Asbestos?  
A. A group of naturally occurring fibrous silicate 
minerals. 
B. A fibrous substance used widely throughout the 
United States in the construction, shipbuilding, 
and automotive industries until the 1970s. 
C. A heat-stable substance commonly used in 
insulation, pipe coverings, boilers, brake pads, 
and many other products. 
D. all of the above. 
2. Which asbestos exposure pathway most commonly leads 
to illness?  
A. Ingestion. 
B. Inhalation. 
C. Dermal contact. 
D. All are equally important. 
3. Of the following, in the United States, the people in the 
general population most at risk of exposure to asbestos 
today is  
A. people who work in asbestos mining and milling. 
B. household contacts of workers engaged in the 
manufacture of asbestos-containing products. 
C. people working or living in homes and buildings 
with loose, crumbling, or disturbed asbestos 
materials. 
D. people who garden with vermiculite potting soil. 
4. OSHA requires workers who are exposed to asbestos at 
levels higher than the PEL of 0.1 fibers/cc of air (8-hour 
TWA) to  
A. receive medical surveillance. 
B. be hospitalized immediately. 
C. file claims for work-related injuries. 
D. all of the above. 
5. After inhalation, asbestos fibers  
A. are retained in the lungs, especially the lower 
lung fields. 
B. initiate responses that can lead to fibrosis of lung 
tissue. 
C. initiate responses that can lead to 
carcinogenesis. 
D. all of the above. 
6. Of the four respiratory conditions associated with 
asbestos exposure, the condition that is not malignant 
but is associated with significant restrictive deficits is  
A. parenchymal asbestosis. 
B. asbestos-related pleural abnormalities. 
C. lung carcinoma. 
D. pleural mesothelioma. 
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7. Which condition is most likely to occur secondary to 
asbestos-associated pulmonary fibrosis?  
A. Peritoneal mesothelioma. 
B. Colon cancer. 
C. Cor Pulmonale. 
D. Constrictive pericarditis. 
8. The most important risk factor for asbestos-associated 
diseases are  
A. genetic polymorphisms and exposure to air 
pollution. 
B. total exposure to asbestos and smoking. 
C. frequency of respiratory infections and 
coexistence of other fibrotic respiratory 
conditions. 
D. all are equally important. 
9. A 64-year-old male who worked in shipyards in the 
United States in the 1960s and 1970s presents to his 
physician complaining of breathlessness, especially 
when he works or exercises. He says this symptom 
began several years ago but was so minor that he was 
not concerned. He also complains of a slight, nagging 
dry cough. Of the asbestos-associated diseases, the 
most likely culprit is  
A. parenchymal asbestosis. 
B. asbestos-related pleural abnormalities. 
C. lung carcinoma. 
D. pleural mesothelioma. 
10. On auscultation of the patient described above, you are 
most likely to hear  
A. normal breath sounds. 
B. absent breath sounds. 
C. bibasilar end inspiratory rales. 
D. rhonchi. 
11. As part of taking the exposure history, you should 
explore  
A. possible occupational exposures to asbestos. 
B. possible paraoccupational and secondary 
exposures to asbestos. 
C. use of personal protective equipment. 
D. all of the above. 
12. Pulmonary function tests of a patient with parenchymal 
asbestosis are most likely to show  
A. normal results. 
B. low FVC. 
C. low FEV1. 
D. low FEV1/FVC. 
13. On chest radiograph, small, irregular opacities in the 
bases of both lung fields is suggestive of  
A. parenchymal asbestosis. 
B. pleural plaques. 
C. benign asbestos pleural effusion. 
D. diffuse pleural thickening. 
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14. In caring for a patient who was exposed to asbestos, it 
is important to  
A. take steps to avoid further exposure to asbestos. 
B. counsel the patient to stop smoking. 
C. monitor the patient to facilitate early diagnosis. 
D. all of the above. 
15. Patients diagnosed with an asbestos-associated disease 
should be instructed to  
A. continue working with asbestos as long as they 
use PPE. 
B. contact their doctor if they develop any sign of 
respiratory infection or other health change. 
C. receive influenza and pneumococcal vaccines 
only if they meet other criteria for being high 
risk. 
D. all of the above. 
16. Asbestos fibers are released into the air mainly when  
A. asbestos-containing materials are loose, 
crumbling, or disturbed. 
B. asbestos is fixed in solid materials such as 
wallboard. 
C. asbestos-bearing rock lays unexposed deep 
underground. 
D. all of the above. 
17. EPA’s MCL for asbestos in drinking water is which of the 
following?  
A. 0.07 fibers per liter of drinking water. 
B. 7 million fibers per liter of drinking water. 
C. 700 fibers per liter of drinking water. 
D. 70,000 fibers per liter of drinking water. 
18. Diffuse interstitial fibrosis resulting from inhalation of 
asbestos fibers and producing restrictive lung disease 
and progressive exertional dyspnea is termed  
A. lung carcinoma. 
B. pleural mesothelioma. 
C. parenchymal asbestosis. 
D. asbestos-related pleural abnormalities. 
19. Asbestos-related pleural abnormalities include which of 
the following?  
A. Pleural plaques. 
B. Benign pleural effusions and diffuse pleural 
thickening. 
C. Rounded atelectasis. 
D. all of the above 
20. The most typical abnormal finding on physical 
examination of a patient with significant asbestosis is  
A. a “doughy” feeling in the abdomen. 
B. bibasilar inspiratory rales on pulmonary 
auscultation. 
C. clubbing of the fingers. 
D. all of the above. 
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21. The two most important tests for diagnosing asbestos-
associated diseases are  
A. BAL and lung biopsy. 
B. CT and HRCT scans. 
C. chest radiograph and pulmonary function tests. 
D. blood studies and colon cancer screening. 
22. Managing parenchymal asbestosis involves  
A. smoking cessation. 
B. regular influenza and pneumococcal vaccines. 
C. respiratory therapies and pulmonary 
rehabilitation. 
D. all of the above. 
23. Patients who were exposed to asbestos should  
A. stop smoking. 
B. avoid exposure to other respiratory irritants. 
C. avoid exposure to respiratory infections and 
contact their doctor if they get signs of infection 
or other health changes. 
D. all of the above 
 
Page 69 of 73 
 
Agency for Toxic Substances and Disease Registry Asbestos Toxicity 
Case Studies in Environmental Medicine (CSEM) 
 
 
Relevant Content To review content relevant to the posttest questions, see: 
Question Location of Relevant Content 
What Is Asbestos? 
Where Is Asbestos Found?
1 
2 How Are People Exposed to Asbestos?
3 Who Is at Risk of Exposure to Asbestos?
4 What Are U.S. Standards for Asbestos Levels?
What Is the Biologic Fate of Asbestos? 
How Does Asbestos Induce Pathogenic Changes?
5 
6 What Respiratory Diseases Are Associated with Asbestos?
7 What Other Diseases Are Associated with Asbestos?
How Should Patients Exposed to Asbestos Be Evaluated? 
What Instructions Should Be Given to Patients?  
8 
9 How Should Patients Exposed to Asbestos Be Evaluated?
10 How Should Patients Exposed to Asbestos Be Evaluated?
11 How Should Patients Exposed to Asbestos Be Evaluated?
12 What Tests Can Assist with Diagnosis of Asbestos Toxicity?
13 What Tests Can Assist with Diagnosis of Asbestos Toxicity?
14 How Should Patients Exposed to Asbestos Be Treated?
15 What Instructions Should Be Given to Patients?
16 Where Is Asbestos Found?
17 What Are U.S. Standards for Asbestos Levels?
18 What Respiratory Conditions Are Associated with Asbestos Exposure?
19 What Respiratory Conditions Are Associated with Asbestos Exposure?
20 How Should Patients Exposed to Asbestos Be Evaluated?
21 What Tests Can Assist with the Diagnosis of Asbestos-Related Diseases?
22 How Should Patients Exposed to Asbestos Be Managed and Treated?
23 What Instructions Should Be Given to Patients?
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